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1.     Introduction
1.1.     Adherens junctions
Cell-cell adhesion is an important process that is dynamically rearranged and
regulated in various situations including tissue development, the establishment of
epithelial cell polarity, and wound healing (Adams and Nelson, 1998; Gumbiner,
2000; Takeichi, 1995). In mammals, adhesion between epithelial cells is generally
mediated by three types of junctions: namely tight junctions (TJs), adherens
junctions (AJs) and desmosomes, which together constitute the Intercellular
Junctional Complex. The complexes contain transmembrane receptors, usually
glycoproteins that mediate binding at the extracellular surface and determine the
specificity of the intracellular response. The associated cytoplasmic proteins of these
receptors structurally link them to the cytoskeleton, hence establishing
communication to other cell-cell junctions and to cell-substratum junctions. The
linkage of cell-cell junctions allows single cells of an epithelial sheet to function as a
coordinated tissue. Additional proteins assist in connecting structural and signaling
elements, and thus intercellular junctions function to integrate a number of cellular
processes ranging from cytoskeletal dynamics to proliferation, transcription, and
differentiation (reviewed in Perez-Moreno et al., 2003).
1.1.1.     E-Cadherin and its associated proteins
The transmembrane core of AJs consists of cadherins, which cluster at sites of cell-
cell contacts in most solid tissues. The best characterized member of the cadherin
family is E-cadherin, an epithelial cadherin which is important for the induction of
epithelial cell-surface polarity and mediates the establishment of AJs. It is also
required for the compaction of preimplantation embryos in early development (Larue
et al., 1994). E-cadherin has been characterised as a tumor-suppressor molecule.
Any mutation in the E-cadherin gene, its downregulation, or the hypermethylation of
its promoter are associated with tumor progression (Takeichi, 1993; Birchmeier et
al., 1993; Christofori and Semb, 1999).
E-cadherin exhibits calcium dependent homophilic interactions with other cadherin
molecules on the neighbouring cells via its extracellular portion. It is connected to
the cytoplasm by its cytoplasmic tail that binds to β-catenin/plakoglobin which is
further connected via α-catenin (an adaptor protein) to the cytoskeleton (Fig. 1).2
Alternatively,  α-catenin binds to the Rac1/Cdc42 effector protein, IQGAP1, when
displaced from the cadherin-catenin complexes (Kaibuchi et al., 1999), which occurs
only in the case of negative regulation of cell-cell adhesion (Kuroda et al., 1998).
The linkage of E-cadherin to the cytoskeleton via the catenins stabilises the
cadherins at the junctions hence facilitating cell-cell adhesion. The juxtamembrane
domain of the cadherins binds to p120 (Reynolds et al., 1994), although the
functional implication of this binding is not really clear. The protein p120
ctn has been
shown to act both as a positive and negative regulator of cadherin adhesiveness
(Anastasiadis and Reynolds, 2001). Recent evidence using a p120ctn-deficient cell
line has implicated a crucial role for p120-E-cadherin interaction not only for the
proper localisation and function of E-cadherin but also an increase of protein
expression (Ireton et al., 2002).
Figure 1. E-cadherin based adherens junctions.
Apart from being an important component of the cell adhesion machinery by linking
cadherins to the cytoskeleton, β-catenin is also a pivotal component of the
Wnt/Wingless (Wg) signaling pathway which plays a key role in various
developmental processes (Cox and Peifer, 1998; Willert and Nusse, 1998). The
Extracellular
Cadherin
α-catenin
β-catenin
α -actinin
vinculin
actin
Nucleus
Regulation of 
transcription
Regulation
of stability
Epithelial cell
β-catenin
p120
p120
pg
IQGAP13
cellular level of the β-catenin protein, as well as its subcellular localization are very
tightly regulated. When not associated with cell-cell junctions, β-catenin is
incorporated into a large complex that includes the APC tumor suppressor gene, the
GSK-3β serine/threonine protein kinase, and the axin/conductin protein (Behrens et
al., 1998; Hart et al., 1998; Ikeda et al., 1998). Activation of the Wnt/Wg pathway
blocks this degradation, giving rise to an increased pool of free β-catenin that
translocates into the nucleus and subsequent on binding to TCF/LEF family of
transcription factors, stimulates transcription of some oncogenes and a variety of
unknown target genes (Behrens et al., 1996; Molenaar et al., 1996; Riese et al.,
1997; van der Wetering et al., 1997). The deregulation of β-catenin leading to an
increased free pool has been associated with various types of cancer (Clevers and
van de Wetering, 1997; Gumbiner, 1997; Peifer, 1997; Bullions and Levine, 1998).
The important role of stabilising intercellular junctions and coordinating actin
dynamics at these sites is performed by α-catenin, a key regulator of the cadherin-
catenin complex. α-catenin binds to other cytoskeletal elements such as vinculin, α-
actinin, ZO-1 and actin (Imamura et al., 1999). The binding of α-catenin to the
nectin-afadin complex (Mandai et al., 1999) is necessary for the recruitment of E-
cadherin to the nectin-based cell-cell adhesion sites and is involved in the formation
of E-cadherin based AJs (Fig. 2). Vezatin, another newly identified member of the
AJs interacts with α-catenin and bridges myosin VIIA to the cadherin-catenins
complex, probably strengthening cell-cell adhesion (Küssel-Adermann et al., 2000).
The binding of α-catenin to these newly identified members of the AJs contributes to
the organisation of the junctional complex by being responsible for the proper
localisation of these molecules (Küssel-Anderman et al., 2000; Tachibana et al.,
2000).
Additionally, some novel PDZ proteins have been identified that may form
complexes with basic AJ components to establish mature AJs in non-epithelial and
epithelial cells. PDZ domains are basically protein-protein interactions domains that
can interact with short carboxyl-terminal peptide motifs or with other PDZ domains
(Fanning and Anderson, 1999). PDZ proteins localized at AJs may play a role in
regulating the localization of interacting proteins, including adhesion molecules,
receptors and signaling proteins. One of the two newly identified PDZ proteins of the
adherens junctions include LIN-7 that occurs in a LIN-2-LIN-7-LIN-10 protein4
complex that is involved in the organization of epithelial and neuronal junctions in C.
elegans and mammals (Margolis et al., 1999). The other protein is Arc protein (Liu et
al., 2000) which is also present in AJs in Drosophila, the exact function for which is
not yet deciphered although it exhibits a highly regulated pattern in developing
embryonic epithelial tissues.
Another potential partner identified for E-cadherin is the presinilin 1 (PS1) protein
involved in Alzheimers disease. It has been reported that PS1 directly binds to E-
cadherin, although whether this association stabilises E-cadherin (Baki et al., 2001)
or targets E-cadherin for cleavage and AJ disassembly (Marambaud et al., 2002) is
not yet clear. Additionally, PS1 facilitates the stepwise phosphorylation of β-catenin
that targets it for degradation, and conversely, loss of PS1 leads to stabilisation of β-
catenin, enabling it to function outside AJs (Kang et al., 2002). These findings as
well as its broad expression in epithelia suggest that its regulation may impact on
AJ-cytoskeletal dynamics.
Understanding of this complex network of proteins and their regulation at the AJs will
provide much deeper insight into understanding the dynamic regulation of AJs
during development and disease.
Figure 2. Protein complexing at the AJs. Stable interactions are depicted by a straight line ,
colocalisation and/or possible direct interactions are depicted by a dashed line.
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1.1.2.     Regulation of the adherens junctions
Adherens junctions are highly dynamic structures that can undergo rapid but
nevertheless regulated assembly and disassembly, as in epithelial-mesenchymal
transitions. Such processes are needed, for example, when cells decrease the
strength of their adhesion in order to move. If deregulated in pathological situations
these phenomena may participate in establishing invasion and metastasis of
carcinomas, as has been shown in many cases (Shimoyama and Hirohashi, 1991;
Shiozaki and Mori, 1991; Takeichi, 1991).
As mentioned above, E-cadherin plays a central role in the establishment of
epithelial adherens junctions. The dynamics of the regulation of the AJs are quite
dependent on the cadherin-catenin complexes and their associated proteins. The
major factors that are involved in the regulation of these components and hence in
the regulation of the AJs are summarised below:
a)     Posttranslational modifications
The phosphorylation of E-cadherin by casein kinase II (CKII) and glycogen synthase
kinase-3β (GSK-3 β) increases the affinity of E-cadherin for β-catenin, thus
enhancing E-cadherin mediated cell-cell adhesion (Huber and Weis, 2001; Lickert et
al., 2000). CKII has also been shown to phosphorylate β-catenin at serine/threonine
residues and in addition to stabilising the protein, it also increases its adhesion with
α-catenin, thus stabilising the cadherin adhesion complex (Bek and Kemler, 2002).
Tyrosine phosphorylation is also known to play a major role in the regulation of E-
cadherin function: β-catenin is tyrosine phosphorylated by the non-receptor tyrosine
kinase SRC, this modification leads to disassembly of the cadherin-catenin
complexes and subsequent loss of cell adhesion (Behrens, 1993; Hamaguchi et al.,
1993). Moreover, β-catenin has also been shown to be phosphorylated by receptor-
tyrosine kinases, epidermal growth factor receptor (EGFR) and c-met (also known
as scatter factor or hepatocyte growth factor receptor) (Hoschuetzky et al., 1994).
Increased tyrosine phosphorylation of β-catenin is frequently found in colorectal
cancer (Takayama et al., 1998).
An interaction partner of E-cadherin-Hakai, has been identified that binds to E-
cadherin in a phosphotyrosine dependent manner causing the shuttling of
internalised E-cadherin to the lysosome rather than recycling it back to the plasma6
membrane (Fujita et al., 2002). Thus, it has been concluded that Hakai has the
ability to regulate adhesion by modulating the amount of cell surface cadherin.
b)     Role of small GTPases
The Rho family of small GTPases (includes RhoA, Rac1 and Cdc42) is known to
regulate cell shape, cell growth and cell polarity (Tapon and Hall, 1997). Rac1 and
Cdc42, together with their exchange factor Tiam-1, also regulate cadherin-mediated
cell-cell adhesion (Braga et al., 1997; Jou and Nelson, 1998). This has been shown
to be regulated by IQGAP1, a target molecule of Cdc42 and Rac1. IQGAP1 induces
the dissociation of α-catenin from the E-cadherin cell-adhesion complex by
competing with α-catenins binding to β-catenin.; this results in the loss of E-cadherin
mediated adhesion by inhibiting its association to the cytoskeleton (Kuroda et al.,
1998).
Rac1 has additionally been implicated in the regulation of adherens junctions via
clathrin independent (involving caveolae) endocytosis of E-cadherin (Akhtar and
Hotchin, 2001) and has a possible role in the dynamic rearrangement of E-cadherin-
mediated cell-cell adhesion since the E-cadherin endocytosed via activated Rac1 is
not fated for degradation albeit for recycling. This group highlighted for the first time
the emerging role of caveolin-1, a major coat protein of caveolae, in the dynamics of
AJs.
c)     Transcriptional regulation
The transcriptional regulation of E-cadherin controls E-cadherin levels and hence the
adhesive interactions during tissue remodelling events. A well studied  element of
the E-cadherin promoter is an E-box which binds factors such as Snail, Slug,
E12/E47, and SIP to promote transcriptional repression of the E-cadherin gene
(Bolos et al., 2003). Genetic ablation of snail in mice results in early embryonal
abnormalities, including the development of a mesoderm with epithelial
characteristics such as AJs and apical-basal polarity (Carver et al., 2001).
Conversely, overexpression of snail and its cousin slug results in epithelial to
mesenchymal transitions (EMTs) in vitro (Bolos et al., 2003). EMTs play a broad role
in the normal development of tissues, including kidney and skeletal muscle. Snail
has also been implicated in specifying mesodermal fate during gastrulation (Carver
et al., 2001; Ciruna and Rossant, 2001). A variety of epithelial cancers show7
elevation of these repressor proteins, and this correlates with tumor invasiveness
(Comijn et al., 2001).
1.2.     Caveolin-1
Caveolae are plasma membrane specializations of 50-100 nm that exist in two
different forms: (a) as invaginations of the plasma membrane and (b) as vesicles
residing near the membrane. They are found in many cell types, but are notably
abundant in fibroblasts, adipocytes, endothelial cells, type I pneumocytes, epithelial
cells, and smooth and striated muscle cells (Couet et al., 1997a). Fig. 3 shows the
electron microscopy picture of caveolae at the membrane. The chief structural
proteins of caveolae are caveolins. Three caveolins genes known so far are:
caveolin-1, caveolin-2 and caveolin-3. While caveolin-1 and caveolin-2 are
ubiquitously expressed, caveolin-3 occurs specially in muscle tissue.
Figure 3. Caveolae at the plasma membrane as visualised by electron microscopy.
Caveolins are integral membrane proteins with a hydrophobic segment of 33-amino
acids and form a hair pin like structure with both N- and C- terminus in the cytoplasm
(Kurzchalia et al., 1992 and 1994). Three important functional roles have been
designated to caveolins:
1.  the principle structural components of caveolae membranes8
2.  shuttle proteins in the biosynthetic trafficking of cholesterol from the ER to the
plasma membrane
3.  scaffolding proteins to organize and inactivate signaling molecules that are
concentrated on the cytoplasmic surface of caveolar membranes.
Caveolin-1 was first identified by Glenney and co-workers as a major v-src substrate
in Rous sarcoma virus-transformed chicken embryo fibroblasts (Glenney, 1989;
Glenney and Lucille 1992; Glenney and Soppet 1992). Thus, caveolin-1 was first
discovered in the context of tyrosine phosphorylation, signal transduction, and cell
transformation.
Only later was caveolin-1 found to be a component of the caveolar coat (Rothberg
and Artavanis-Tsakona, 1992). It plays an important role in the biogenesis of
caveolae through its ability to form homo-oligomers and its direct interaction with
cholesterol and probably glycosphingolipids.
Along the lines that caveolin family members function as scaffolding proteins (as
mentioned above), caveolin-1 was found to suppress the kinase activity of Src family
tyrosine kinases (c-Src/Fyn), epidermal growth factor receptor (EGFR), Neu, and a
protein tyrosine kinase C through the caveolin-scaffolding domain, a modular protein
domain that recognises a specific caveolin binding motif in various signaling
molecules (Couet et al., 1997a; Okamoto et al., 1998; Couet et al., 1997b). In
addition, the scaffolding domain of caveolin-1 has been shown to inhibit endothelial
nitric–oxide synthase activity and the GTPase activity of heterotrimeric G-proteins (Li
et al., 1995; Li et al., 1996; Song et al., 1996; Razani et al., 1999, Garcia-Cardena et
al., 1997). The constitutive activation of these signaling molecules leads to cell
transformation. Since the interaction of caveolin-1 via its scaffolding domain
(Okamoto et al., 1998) with these signaling molecules leads to their inactivation,
caveolin-1 has been found to play an important role as a tumour suppressor protein
(Koleske et al., 1995; Engelman et al., 1997; Galbiati et al., 1998).
This role of caveolin-1 as a tumor suppressor has been shown in many different
reports:
1.  It has been seen that caveolin-1 gene is localised to a suspected tumour
suppressor locus (7q31.3), a known fragile site (FRA7G) that is deleted in many
types of cancer (Engelman et al., 1998). Thus, downregulation of caveolin-1
expression and caveolae organelles might be critical for the induction and the
maintenance of  the transformed phenotype.9
2.  The level of caveolin-1 mRNA and protein expression are either lost or reduced
during cell transformation by activated oncogene products such as v-Abl and Ha-
Ras (Koleske et al., 1995). Induction of caveolin-1 expression in v-Abl and Ha-Ras
transformed NIH 3T3 cells abrogated the loss of anchorage-independent cell growth
and led to the formation of caveolae (Engelman et al., 1997).
3.  It has been shown by the group of Galbiati et al (1998) that antisense mediated
functional knockout of caveolin-1 leads to the oncogenic transformation and
constitutive activation of the p42/44 mitogen-activated protein kinase (MAPK)
cascade.
4.  Caveolin-1 has also been shown to regulate contact inhibition and growth arrest
in nontransformed cells (Galbiati et al., 1998; Volonte et al., 1999), hence raising the
possibility of its being involved in cell adhesion processes.
5.  It has been shown by Galbiati et al (2000), that caveolin-1 expression inhibits
Wnt/β-catenin/Lef-1 signaling by recruitment of β-catenin to caveolae membrane
domains. This is also quite interesting in the context of cell-cell adhesion since
caveolin-1 also forms a complex with E-cadherin and β-catenin most probably via its
direct interaction with β-catenin. This makes caveolin-1 an additional important
candidate for studying the complex mechanism of cell-cell adhesion.
1.3.     Endometriosis
The invasive but benign disease endometriosis is one of the most frequent diseases
in gynaecology, affecting up to 15-20% of women during the reproductive stage and
causes infertility in up to 50% of women (Goldman and Cramer, 1990).
Endometriosis is characterized as the ectopic presence of endometrial glands and
stroma outside the uterine cavity, which undergo cyclic proliferation and breakdown
similar to eutopic endometrium. Ectopic lesions are mainly located in the peritoneal
cavity and ovaries (Jenkins et al., 1986; Halme et al., 1998). Furthermore, infiltrating
lesions are found for example in the colon, kidney, liver, lungs and pancreas. Thus,
the endometriotic cells are able to penetrate organs of the pelvic cavity or more
distant organs after spreading via the blood stream or lymphatic system.
The aetiology and pathophysiology of the disease remains poorly understood.
Different theories have been proposed to explain the onset and progress of this
disease:10
•  Implantation theory: This theory postulates that the majority of endometriotic
lesions are derived from viable eutopic endometrial cells that are transported to the
peritoneal cavity by retrograde menstruation, which then adhere to the peritoneal
wall, proliferate and form endometriotic lesions (Sampson 1940).
•  Metaplasia theory: According to this theory, endometriosis might also be
established by hormone-dependent transformation of peritoneum into Mullerian-type
epithelium (Fuji 1991). This metaplasia theory is supported by rare cases of
endometriosis in men and in women without retrograde menstruation or abnormal
fallopian tubes (Suginami 1991).
Both theories are variations of the initial development of endometriotic lesions.
Until now, no theory has come up which explains the growth and differentiation of
endometriosis and also why implantation and endometriosis do not occur in all
women, inspite of the fact that retrograde menstruation occurs in almost all women.
There is still no explanation to why deep and ovarian endometriosis or endometriotic
disease does not develop in all women with subtle and/or minimal endometriosis and
why some women develop cystic ovarian and other deep endometriosis, nor why
deep lesions can be present as infiltration, or retraction or adenomyosis externa
(Koninckx et al., 1991).
1.3.1.     Factors involved in endometriosis
Different factors that are involved in endometriosis have been identified such as i)
Peritoneal fluid that contains in women with endometriosis an increased number of
activated macrophages that secrete a variety of cytokines, including interleukin IL-6,
IL-8, vascular endothelial growth factor, and tumor necrosis factor-α TNF-α
(reviewed in Giudice et al., 1998), ii) Ovarian steroids , whereby it is shown that high
levels of estrogen is related to increased incidence of endometriosis (Halme et al.,
1998), iii) Extracellular matrix and its components which involve the matrix
metalloproteinases (Osteen et al., 1996), different ligands such as tenascin,
fibronectin isoforms and integrins α3,  α6,  and  αvβ3  (Rai et al., 1996; Lessey and
Young, 1997) and iv) the adhesion molecules such as E-cadherin which is
expressed in all endometrial samples, but could only be detected in 40% of
menstrual effluent samples (van der Linden et al., 1994). This shows that the loss of
cell adhesion properties might play a role in the shedding of endometrial tissue11
during menstruation and the detached endometrial tissue can attach to the
peritoneum, thereby leading to endometriotic lesions.
The study of molecular, cellular and pathophysiological parameters governing
endometriosis is hampered by a lack of in vitro model systems, such as
endometriotic cell lines. To overcome this problem, cell lines were established
successfully for the first time in our group, from peritoneal biopsies and were
characterised at the molecular and cellular level (Zeitvogel et al., 2001). For the
preparation of the cell lines, cells from peritoneal endometriotic biopsies were taken
into culture and are subsequently transformed with SV40 T antigen for immortality.
Two types of cells could be transformed i) exhibiting stromal cell features
(cytokeratin/E-cadherin negative) ii) epithelial-like (cytokeratin positive/E-cadherin
negative), which proved as invasive as metastatic carcinoma cells, as measured
with a matrigel invasion assay. This could be the influence of N-cadherin implicated
as a path finding cadherin allowing cellular invasion and migration in both normal
and pathophysiological processes. These results supported the idea that
endometriosis, although not neoplastic, shares features with malignant cells and that
metastasis in endometriosis may include mechanisms proposed for micrometastasis
in cancer. Thus, these cell lines could serve as a useful tool for analysing molecular
and cellular events relating to endometriosis as well as representing a paradigm for
invasion and metastasis in general.
1.4.     Shrew-1
One of the cell lines that was established for investigation of molecular and cellular
mechanisms involved in the invasiveness of endometriosis, was EEC145T
(Zeitvogel et al., 2001). This cell line shared common features with other established
endometriotic cell lines in our lab, i.e. was E-cadherin negative, cytokeratin positive
and was invasive in a collagen invasion assay (Zeitvogel et al., 2001). However, a
peculiar feature of the EEC145T was that at approximately passage 25, this cell line
started losing its invasive features and downregulating cytokeratin expression
without changing the proliferative potential.
To analyse the molecules differentially expressed in the invasive and the non-
invasive passages, Differential Display Reverse Transcriptase PCR  (DDRT-PCR)
with an invasive (p17) and a non-invasive (p33) passage of this cell line was12
performed (Bharti et al., in press). This reproducibly resulted in the isolation of a 391
bp DDRT-PCR fragment (Fig. 4A)  that was differentially expressed in the invasive
form of EEC145T cell line. Cell lines EJ28, RT112 and the late passage of EEC145T
did not seem to have any shrew-1 mRNA (Fig. 4B). It could also be shown that
shrew-1 mRNA was not detected in normal endometrium, but only in endometriosis
(Handrow-Metzmacher, unpublished). With Northern blot analysis, it could be shown
that this 391 bp fragment hybridised to a transcript of 4 Kb in different tissues such
as pancreas, kidney, spleen and brain, in addition to a 9 Kb message in the brain,
generating the possibility of two isoforms or two different promoters leading to two
different transcription initiation sites (Handrow-Metzmacher, unpublished).
Database searches in NCBI for sequences identical to shrew-1 DDRT cDNA
sequences also revealed ESTs with identical sequences from whole brain, kidney,
lung epithelia, pooled, spleen, 2 pooled Wilms tumors-one primary and one
metastatic to brain, primary lung cystic epithelial cells, synovial membrane and
hippocampus. Table 1 also shows some tissues that tested positive for shrew-1
expression in our lab by in situ hybridisation (Klemmt, unpublished).13
Figure 4. (A) Diagram depicting DDRT-PCR performed with invasive and non-invasive passages of
the endometriotic cell line EEC145T, leading to the identification of shrew-1 mRNA. (B) The 391 bp
cDNA was used as a probe to test for the presence of shrew-1 mRNA in endometriotic and carcinoma
cell lines. Poly A+ RNA was prepared from the cell lines EJ28  (invasive bladder carcinoma), RT112
(non-invasive bladder carcinoma), EEC145T (p17 = invasive passage 17; p33 = non-invasive
passage 33 of the endometriotic cell line) and Per 143T (peritoneal cells immortalised with SV40 T
antigen). A Northern blot probed with 
32P-labelled shrew-1 probe detected an mRNA of about 4 kb in
the invasive endometriotic cell line. Lower panel: the membrane was reprobed with cytochrome C
oxidase to check the integrity and loading of the RNA samples.
Screening of a ZAP Express 
TM /EcoRI/XhoI custom cDNA phage library constructed
from RNA of invasive passage p17 of EEC145T led to the isolation of phagemid
clone Q2A containing an insert of 2204 nucleotides including the original DDRT-PCR
fragment. The genomic sequence of shrew-1 isolated by NCBI data bank showed
shrew-1 to be present on chromosome 1p36.
The exon structure deduced from this shrew-1 nucleotide sequence of 2204
nucleotides consists of 5 exons, with the original DDRT-PCR sequence in the exon
5. The longest open reading frame (ORF) found consisted of a stop codon in the
exon 4, leading to the conclusion that the original shrew-1 fragment isolated was a
part of the 3´UTR of the shrew-1 mRNA.
EEC145T
Invasive
mRNA
Differential Display RT-PCR
Non-invasive
Identification of shrew-1 mRNA 
from invasive cells
4268 bp
3530 bp
2027 bp
EJ28
RT112
Per 143T
Shrew- 1
EEC 145T,p17
EEC 145T,p33 AB14
TISSUES CARCINOMAS
Large intestine Kidney
Embryo Liver metastatis
Endometriosis Endometriosis
Endometrium Pancreatic carcinoma
Heart Breast cancer(ductular)
Pancreas Breast cancer(lobular)
Placenta Lung carcinoma
Spleen
Prostrate gland
Ovary
Skeletal muscle
Thymus
Table 1. Tissues positive for shrew-1. Summary of expression analysis of shrew-1 in various epithelial
tissues and carcinomas by in situ hybridisation.
A polyadenylation signal in the deduced cDNA sequence at the 3´ end was isolated
which was most probably the transcription termination site of the shrew-1 mRNA.
Further attempts were done to deduce the sequence more towards the 5´ end to
isolate the complete 4 Kb nucleotide stretch. The rest of the cDNA was isolated by
exon trapping experiments and 5´ and 3´ RACE experiments using commercially
available Marathon-Ready
TM cDNA from human brain, which is also positive for
shrew-1. The cDNA finally obtained contained 2910 nucleotides and was identical to
mRNA sequences in the EEC145T cells as revealed by overlapping RT-PCRs and
DNA sequencing (accession number AX009358). This cDNA encoded an ORF of
411 amino acids (Handrow-Metzmacher, unpublished).
1.4.1.     Alternative splicing of shrew-1
Different alternatively spliced products of shrew-1 were identified with further RACE
and exon trapping experiments (Fig. 5). The spliced variants at the 5´end consisted
of exon 0 and exon 0a. Exon 0a does not contain any translation initiation site
whereas exon 0 contains one translation initiation site. At the 3´end, exon 4a was15
isolated as an alternatively spliced product, in between exon 4 and exon 5. However,
the splicing at the 3´end did not seem to be of any significance to the protein
encoding region since the translation was terminated in exon 4. However, this could
have an influence over the stabilisation of transcript of shrew-1 (Handrow-
Metzmacher, unpublished).
Further work in this thesis has been done on the cDNA encoding the longest ORF of
411 amino acids, referred to as shrew-1.
Figure 5. Alternative splicing of shrew-1 at the 5´ and at the 3´ end. The longest open reading frame
(ORF) obtained consisted of 411 amino acids.
1.4.2.     shrew-1 protein
Shrew-1 was predicted by computational analysis to have a cleavable signal peptide
of 43 amino acids, a transmembrane domain of 20 amino acids, some low
complexity regions within the putative extracellular domain and a putative
cytoplasmic domain (Fig. 6A). This points towards the evidence that shrew-1 might
be a transmembrane protein (Bharti et al., in press). The relevance of this prediction
will be tested further in this thesis.
The amino acid composition (Fig. 6B) of shrew-1 predicts a highly alkaline protein
with an isoelectric point of 9.86 and a theoretical molecular mass of 44.5 kDa. No
homology to any other known protein or to any protein domains was found (Bharti et
al., in press). It seems that shrew-1 does not belong to any known protein family.
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Various post translational modifications could be predicted using computer
prediction programs.
These are summarised in table 2.
      A
        B
Figure 6. (A) Computational analysis of shrew-1. SP is the signal peptide constituted of 43 amino
acids, TMD is the transmembrane domain, A is an aldehyde dehydrogenase domain and the various
phosphorylation sites are denoted by P. The predicted orientation of the protein is that the amino
terminus is extracellular and the carboxyl terminus is cytoplasmic. (B) The complete 411 amino acid
sequence of the shrew-1 protein. The putative signal peptide is depicted in bold letters and the
transmembrane domain is underlined. The cytoplasmic domain is marked in red.
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Sequence motif Amino acids             Position
Extracellular   Intracellular
N-glycosylation NLTD
NETL
                          331
                          351
cAMP-and cGMP-dependent protein
kinase phosphorylation sites
RKTT
RRNS
212–215
                           314-317
Protein kinase C phosphorylation
sites
SIR
SFR
SPR
TRK
TRR
SAR
SDR
SEK
13–15
65-67
80-82
211-213
                       313-315
                       337-339
                       392-394
                       403-405
Casein kinase II phosphorylation site SSFD
TETE
TGDE
STTE
SSLD
TTGE
SSSD
165-168
176-179
186-189
251-254
                       342-345
                       376-379
                       390-393
N-myristoylation site GSRPTT
GGVSTT
GVSTTE
GNRPSS
171-176
248-253
249-254
                      386-391
Amidation site RGKR 154-157
Aldehyde dehydrogenases glutamic
acid active site
GEASGLAV 273-280
Table 2. PROSITE analysis of the various posttranslational modifications and their positions in shrew-
1 sequence.
No orthologs of shrew-1 were found in yeast, Drosophila or C.elegans. However, a
homology with an unidentified zebra fish protein was found in the putative
transmembrane and the cytoplasmic domains of the protein. More than 90%
homology was also found with a mouse protein (400 amino acid isoform). This led to
the conclusion that shrew-1 might be required only in higher vertebrates and indeed
is highly conserved in them.18
1.5.     AIMS OF THE STUDY
The identification and isolation of shrew-1, a novel protein from the invasive passage
of the endometriotic epithelial cell line EEC145T was the first major step taken
towards the understanding of the invasive phenotype of endometriotic cells.
However, the identification of ESTs similar to shrew-1 sequence from other tumours
such as Wilms tumours and from colon carcinomas led to the belief that shrew-1 is
not an endometriosis specific protein and is also associated with other carcinomas
as well. At the same time of identification of shrew-1, the group of Kudoh et al.,
(sequence unpublished, accession number AF175409) identified MOT8, a protein
with 100% similarity to shrew-1 from invasive fibrosarcoma cells, further
strengthening its association with tumors. In addition to being upregulated in some
tumors, it is also present in other epithelial tissues such as brain, pancreas, kidney
and spleen.
The first computer analysis predicted it to be a transmembrane protein with a signal
peptide, a putative ectodomain, a strong hydrophobic segment (probably the
transmembrane domain) and a putative cytoplasmic domain. Some posttranslational
modifications such as phosphorylation and glycosylation were also predicted. At the
same time, it was seen that shrew-1 has no homology to any other known protein or
any conserved domain in the sequence. The aim of this work was to characterise
this novel protein which obviously is not a member of any known protein family,
making it difficult to study. In this work, shrew-1 has been characterised with respect
to its cellular localisation, its orientation at the membrane, identification of its
interaction partners and its possible role in invasion.19
2.     Materials and Methods
2.1.     Materials
2.1.1.     Chemicals
The chemicals of analytical quality were used from the companies:
Amersham-Pharmacia, Freiburg/Breisgau
Roche, Mannheim
Biorad, München
Fluka Buchs Pharmacia LKB, Freiburg
Merck Eurolab, Darmstadt
Roth, Karlsruhe
Serva Feinbiochemika, Heidelberg
Sigma-Aldrich, Steinheim
2.1.2.     Biochemicals
Biochemical Company
Adenosinetriphosphate(ATP) Roth
2´-deoxy-adenosine-5´-triphosphate(dATP) Roth
2´-deoxy-cytidine-5´-triphosphate(dCTP) Roth
2´-deoxy-guanosine-5´-triphosphate(dGTP) Roth
2´-deoxy-thymidine-5´-triphosphate(dTTP) Roth
4-6-Diamidino-2-phenylindol-di-hydrochloride (DAPI) Sigma
1 kb DNA ladder size marker Gibco BRL
7b Protein standard ladder(prestained marker) Sigma
NBT/BCIP-Phosphate stock solution Roche
Superfect transfection reagent QIAGEN
Polyfect transfection reagent QIAGEN
Biotin Perbio
2.1.3.     Stock solutions and buffers
For preparation of all stock solutions and buffers, aqua bidest from the “Millipore Q-
Water System” (Millipore) was used. All the solutions and buffers, which could20
become contaminated with nucleic acids and bacteria or which were to be used in
cell culture were autoclaved (for 20 min at 121°C and 1.0 bar pressure) or were
sterile filtered (Sterilfilter: 0.22um Poresize, firm Millipore)
All solutions and buffers which were used for RNA handling were made in 0.1%
DEPC water. For sterility control of the medium used in cell culture, aliquots from
each medium bottle were taken and were incubated for 7-10 d in the incubator and
observed under the microscopic to check for any contamination.
X% Agarose solution
Xg Agarose dissolved in 100 ml 0.5X TBE by heating, not autoclaved
Ampicillin stock solution
100mg/ml Ampicillin-Sodium salt. Dissolved in water and sterile filtered. To be stored
in dark at 4ºC
AP buffer
100mm NaCl
50mM MgCl2
100mM Tris-Cl pH 9.5
Blocking solution
1X PBS
0.2% Tween 20
5% Skimmed milk powder
Blotting buffer for Western Blot
25mM Tris HCl, pH8.8
150mM Glycine
5% or 10% Methanol
Coomassie solution
42.5% Ethanol(v/v)
10% Acetic acid(v/v)
5% Methanol
2.5g/l Coomassie-blue(Sigma)
Coimmunoprecipitation buffer
10 mM Tris, pH 8.0
150 mM NaCl21
5 mM EDTA
1% Triton X-100
60 mM n-octyl-glucoside
Dissolved in 50ml 1XPBS and added 1 tablet of complete
TM  Protease Inhibitor
cocktail (Roche)
DEPC Water
0.1% Diethylpyrocarbonat(v/v) in aqua bidest. Autoclaved 12 hours after adding
DEPC.
DMEM
13.38 g/l DMEM-Powdered medium ( 4500 mg/l Glucose; Gibco )
3.7 g/l NaHCO3
pH 6.8 set with 1 M HCl
sterile filtered and stored at 4ºC
DNA ladder
15 µl 1Kb DNA ladder
60 µl DNA Sample buffer
225 µl dd H2O
DNA-Sample buffer
0.1% Bromophenolblue (w/v)
0.1% Xylencyanol FF (w/v)
10mM EDTA
40% Glycerin(v/v)
Do not autoclave
Ethidium Bromide Stock solution
10mg/ml EtBr
Unautoclaved and kept in dark , 4ºC.
Ethidiumbromide staining solution
100ul EtBr-Stocksolution
in 1000ul 0.5X TBE in dark, RT.
Fetal calf serum
Mycoplasma tested FCS was used from Sigma.
For long time storage was kept at –80ºC and for regular use was kept at 4ºC.
Freezing medium
10% DMSO22
90% FCS
Hoechst 33258 stock solution (10mg/ml)
0.5 mg/ml Hoechst 33258 stored in dark at 4ºC
Hoechst 33258 working solution (2µg/ml)
Hoechst 33258 stock solution diluted 1:5000 in 1X PBS
Kanamycin stock solution
10mg/ml Kanamycin monosulphate dissolved in water and stored at -20ºC in
aliquots
LB-Medium (1 L)
10g NaCl
10g Casein-Hydrolysate
5g Yeast-Extract
add 1L ddH2O
set pH 7.0 with 5 N NaOH
LB-Agar (1 Liter )
15 g Agar
1l LB medium
Lysozyme stock solution
10mg/ml Lysozyme dissolved in water and stored at -20ºC
3 M Na-Acetate pH 5.2
Dissolve Na-Acetate in ddH2O.
Set pH with 96% acetic acid and autoclaved
NENT Buffer
100mM NaCl
20mM Tris HCl, pH 8
1mM EDTA
0.5% NP40
sterile filtered and stored at 4ºC23
PAA Gel
Resolving gel 8% 10% 12% Stacking gel 5%
50% PAA 1 ml 1.2 ml 1.4 ml 50% PAA 400 µl
1.88 M Tris-HCl
pH 8.8
1.2 ml 1.2 ml 1.2 ml
0.62 M Tris-HCl
pH 6.9
800 µl
2.5% SDS 250 µl 250 µl 250 µl 2.5% SDS 160 µl
H2O 3.5 ml 3.3 ml 3.1 ml H2O 2.64 ml
10% APS 30 µl 30 µl 30 µl 10% APS 20 µl
TEMED 5 µl 5 µl 5 µl TEMED 4 µl
PAA-Gel destaining solution
40% Methanol (v/v)
10% Acetic acid
50% H2O
1xPBS
137mM NaCl
2.6mM KCl
8.1mM Na2HPO4.2H2O
1.5mM KH2PO4
Set pH 7.2-7.4 with HCl
Penicillin/Streptomycin solution
From Gibco BRL
10,000 IU/ml Penicillin(50U/ml)
10,000UG/ml Streptomycin(100ug/ml)
Aliquots stored at 4ºC
RIPA Buffer
150mM NaCl
50mM Tris, pH 7.5
0.5 % Na-Desoxycholate
1% NP 40 (v/v)
1mM EDTA
Dissolved in 50ml 1XPBS and added 1 tablet of complete
TM  Protease Inhibitor
cocktail (Roche).24
1x SDS-Electrophoresis buffer
25mM Tris-HCl
250mM Glycin
0.1% SDS(v/v)
2xSDS Sample buffer
0.125 M Tris pH 6.75
4% SDS
10% β-Mercaptoethanol
20% Glycerine
STET solution
50mM Tris-HCl pH 8.0
50mM EDTA
0.5% Triton X-100(v/v)
8% Saccharose (w/v)
Sterile filtered and stored at 4C.
10X TBE
890mM Tris base
890mM Boric acid
25mM EDTA
1x TBS
150mM NaCl
10mM Tris-HCl pH 7.5
Stored at 4ºC
TFB I buffer TFB II
30 mM Potassium acetat pH 5.8  10 mM MOPS
(Set pH with 2M acetic acid) 75 mM CaCl2
50 mM MnCl2 10 mM KCl
100 mM KCl 15 % Glycerin (v/v)
10 mM CaCl2
15 % (v/v) Glycerin
Filter sterilised and stored at 4ºC25
TWB buffer
20 mM HEPES, pH 7.9
60 mM NaCl
6 mM MgCl2
8.2% Glycerin
0.1mM EDTA
Filter sterilized and stored at 4ºC
Trypsin Solution
0.8 g NaCl
0.4 g KCl
1 g Glucose
0.58 g NaHCO3
1 g Trypsin
0.2 g EDTA
upto 1l H2O
sterile filtered and aliquots kept at 4ºC.
2.1.4.     Restriction endonucleases
The Restriction endonucleases were purchased from Gibco BRL and MBI
Fermentas. These were stored at –20ºC in glycerin containing buffer. They were
used according to the manufacturers protocol with the delivered buffer.
2.1.5.     Nucleic acid modifying enzymes
Enzyme Characteristic Manufacturer
Taq-DNA-Polymerase Polymerase Gibco BRL
Pfu-DNA-Polymerase Polymerase Stratagene
M-MLV Reverse Transcriptase Reverse transcriptase Gibco BRL
2.1.6.     Plasmids
Plasmid Reference
pGEX 5X1  Pharmacia
pGEM®-T Easy  Promega
pECFP-N1  Clontech26
pEGFP-C2, -N3,  Clontech
MOM 70 E-cad M. Rüdiger, Abt. Prof. Jockusch, TU
Braunschweig
pcDNA3.1+/- Fa. Invitrogen
2.1.7.     Bacterial stocks
Stock Reference
E.coli BL21 (DE3) pLysS Studier and Moffat., 1986
E.coli DH5α Bachmann, 1983
2.1.8.     Cell lines
Cell line Description Reference
COS-7 Monkey kidney cells (SV 40 transfected) ATCC: CRL-1651
EJ28 Human invasive Bladdercarcinoma cells Gaetje et al., 1997
HeLa Humane Cervixcarcinoma cells ATCC: CCL-2.1
MCF7 Humane Breast cancer cells ATCC: HTB-22
RT112 Humane, non invasive Bladdercarcinoma cells Gaetje et al., 1997
MDCK Canine kidney epithlial cells ATCC CCl-34
2.1.9.     Molecular Weight Marker
2.1.9.1.     Prestained SDS Molecular Weight Marker SDS-7B (Sigma)
Protein MW (Da)
α-Macroglobulin 180.000
ß-Galactosidase 116.000
Fructose-6-Phosphate kinase 84.000
Pyruvate kinase 58.000
Fumarase 48.500
Lactate-Dehydrogenase 36.500
Triosephosphate-Isomerase 26.600
2.1.9.2.     1 kb-DNA-ladder (Gibco BRL)
Fragment size [bp]
12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 3,054; 2,036; 1,636;
1,018; 517/506; 396; 344; 298; 201; 154; 134; 7527
2.1.10.     Oligonucleotides (primers)
All primers were ordered from Roth and Sigma.
1.     Oligo(dT)-Primer
The Oligo(dT) Primer is used in reverse transcription for the first strand cDNA
synthesis .It hybridises with the poly(A)
+ tail of every mRNA.
Primer Nucleotide sequence (5´–» 3´)
Oligo(dT)-Primer TTTTTTTTTTTTTTTTTTTTTTGGATCCC
2.     BiP-specific Oligonucleotide
The successful cDNA-first strand synthesis can be checked with the help of BiP-
specific oligonucleotides. These oligonucleotides amplify a PCR fragment of 561bp
from the household gene. In case of contamination, an additional band of
approximately 1.2 kb can be detected with these primers.
Primer Nucleotide sequence (5´–»3´)
BiP 5´ TACACTTGGTATTGAAACTG
BiP 3´ GGTGGCTTTCCAGCCATTC
3.     Oligonucleotides for cloning different constructs
Primer Nucleotide sequence (5´–»3´)
trkA-Kpn CGGGGTACCATGCTGCGAGGCGGACGGCG
trkA+Fragoh GACAGCCAGACCTTCGTCCTTCTTCTCCACCG
oh-cd-Frag CTTGTGCTCAACTGCTGTGCCCAAAGCGGG
oh-cpdfrag ATACTGAGCAAGCTTCAAATGGGGAACACTCGT
CGGAACAGCC
bp-cpdfrag CGGGCCCTCTAGATTTCCTGAGGCTTAAACTGTGGG
gfp-cpdfrag CGGGCCCGCGGTACCGCAGGAGATTTCAAACC
FP-Cav-EcoR1 ATCGAATTCATGTCTGGGGGCAAATAC
RP-Cav-Sal1 GGCTCGAGTCGACTTATATTTCTTTCTG
FP-Frag-SP TAGGCTTCGAATTCTATGTGGATTC
FP-ED-ohXP TACGACGATGACGATAAGCTGGGCCCGGGG
RP-SP-ohXP GTCATCGTCGTACAGATCGGCCTCACAGGCGGGCAGGTC
FragGST-1 ACAACTCTTGAATTCAAAAATTGCTGTGCC
FragGST-2 GCTATAGTCGACCAGTCAGCAGGAGATTTCAAA
FP-Frag-TMD TCCGAATTCATGGCTGTCCATCAG28
FP-TCD-HindIII TTTTAAGCTTATGTTCGGTCTGGCTGTC
RP-FragXba1 CCGACAAGATGTCTAGATCAGCAGGAG
RP-FragED GGCGGTACCCTGATGGACAGCCAG
2.1.11.      Plasmid constructs
Construct Vector Restriction
site
Primers Description
trk-GFP pEGFP-N3 Kpn1 trkA-Kpn
gfp-cpdfrag
Ectodomain of trkA,
transmembrane and
cytoplasmic domain
of shrew-1. Linear
amplification.
trk-BP pcDNA 3.1(+) Kpn1,
Hind111
trkA-Kpn
bp-cpdfrag
Same as above
Frag-XP-GFP pEGFP-N3 EcoR1,
Acc651
FP-Frag-SP
FP-ED-ohXP
FP-ED-ohXP
RP-SP-ohXP
Express tag after
signal peptide, c-
terminus GFP tag.
Linear amplification.
CPD-GFP pEGFP-N3 Hind111,
Acc651
oh-cpdfrag
gfp-cpdfrag
Cytoplasmic domain
of shrew-1 fused to
GFP tag
CPD-BP pcDNA 3.1(+) Hind111,
Xba1
oh-cpdfrag
bp-cpdfrag
Cytoplasmic domain
of shrew-1 fused to
BP tag
ED-GFP pEGFP-N3 EcoR1,
Acc651
FP-Frag-SP
RP-FragED
Ectodomain of
shrew-1 fused to
GFP tag
NTD-GFP pEGFP-N3 EcoR1,
Acc651
FP-Frag-SP
RP-FragNTD
Ectodomain and the
transmembrane
domain of shrew-1
fused to GFP tag
TCD-GFP pEGFP-N3 EcoR1,
Acc651
FP-Frag-
TMD, gfp-
cpdfrag
Transmembrane
domain and the
cytoplasmic domain
of shrew-1 fused to
GFP tag
GST-CPD-
Frag
pGEX-5X1 EcoR1, Sal1 FragGST-1,
FragGST-2
Cytoplasmic domain
of shrew-1 fused to
GST tag
GST-cav pGEX-5X1 EcoR1, Sal1 FP-Cav-
EcoR1, RP-
Cav-Sal1
Caveolin-1 fused to
GST tag for bacterial
expression.29
2.1.12.      Antibodies
1.     Primary Antibodies (Monoclonal)
Antibody WB      IP      IF            Reference
Mouse -α-PAN-cadherin 1:1000 1:100 Sigma
Mouse-α-A-Cam 1:100 Sigma
Mouse -α-E-cadherin 5H9 1:1000 1:40 Monosan
Rat-α-E-cadherin DECMA 1:500 undiluted 1:1000 Sigma
Mouse-α-E-cadherin, cl 36 1:2500 1:1000 Transduction Laboratories
Mouse-α-β-catenin, cl 14 1:500 1:100 Transduction Laboraties
Mouse-α-GFP 1:1000 1:500 1:200 Clontech
Mouse-α-Birch profilin 1:500 1:1000 M. Rüdiger, Abt. Prof. Jockusc
TU Braunschweig
Mouse-α-N-cadherin, cl3B9 1:1000 Zymed
Mouse-α-Pyruvate Kinase 1:10 Schebotech
Mouse-α-trkA 1:200 Calbiochem
WB= Western blot; IP= Immunprecipitation; IF= Immunfluorescence
2.     Secondary Antibodies (polyclonal)
                         Antibody    Dilution   Reference
Goat -α-Rabbit IgG (H+L)
Alkaline Phosphatase-conjugated
1:7500 WB Jackson
Goat-α-Maus IgG (H+L)
Alkaline Phosphatase-conjugated
1:7500 WB Jackson
Goat-α-Mouse IgG IgG (H+L)
Peroxidase-conjugated
1:7500 WB  Sigma
Cy3™-conjugated F(ab´) 2 Fragment
Goat-α-Mouse IgG (H+L)
1:200 IF Jackson
Alexa flour™ 594 goat-α-mouse IgG(H+L) Red 1:400 IF Molecular Probes
Alexa flour™ 488 goat-α-mouse IgG(H+L) Green 1:400 IF Molecular Probes
Alexa fluor™594 goat-α-Rabbit IgG (H+L) Red 1:400 IF Molecular Probes
Alexa fluor™594 goat-α-Rabbit IgG (H+L) Green 1:400 IF Molecular Probes
Goat-α-Rabbit IgG (H+L)
Alexa Fluor™594 (red)
1:400 IF Molecular Probes30
2.1.13.     Kits and Transfection Reagents
CONCERT
 High Purity Plasmid Midiprep System (Gibco BRL, Karlsruhe)
CONCERT
 High Purity Plasmid Miniprep System (Gibco BRL, Karlsruhe)
CONCERT
 Rapid Gel Extraction System (Gibco BRL, Karlsruhe)
Effectene Transfection Reagent (QIAGEN, Hilden)
PolyFect
 Transfection Reagent (QIAGEN, Hilden)
QIAquick
® PCR Purification Kit (QIAGEN, Hilden)
TNT
® Coupled Reticulocyte Lysate Systems (Promega)31
2.2.      Methods
2.2.1.     DNA analysis
Restriction digests were performed according to the manufacturers protocol (MBI
fermentas). DNA fragments were purified by “Rapid Gel extraction kit” from Gibco
BRL, Germany. PCR was performed using Pfu Polymerase (Promega) and Taq
polymerase (Gibco). Ligation was performed with T4-DNA Ligase (MBI fermentas,
Germany) according to the manufacturers protocol. Standard procedures were used
for transformation and amplification in E.coli strain DH5α (Sambrook and Russell
2001).
For the quick confirmation of the ligation for cloning, the quick preparation from
Holmes and Quigley, 1981 was used. This is a very quick and easy, but unclean
method for the isolation of plasmid DNA (high copy number) and gives a yield of 3-
5µg from 1 ml of bacterial culture. For the purpose of sending the plasmids for
sequencing to sequencing labs plasmid DNA was prepared from the CONCERT
TM
Rapid Plasmid Miniprep Systems from Gibco BRL. For transfection in eukaryotic
cells or for use in higher amounts, the plasmid DNA was prepared from
CONCERT
TM High Purity Plasmid Midiprep Systems from Gibco BRL.
2.2.1.1.     Expression constructs
Cloning of shrew-trkA chimaeras
The transmembrane domain and the cytoplasmic domain of shrew-1 was fused to
the ectodomain of transforming tyrosine kinase protein (trkA) (Sachs et al. 1996).
The receptor trkA binds with a very high affinity to its ligand-nerve growth factor
(NGF, Review: Barker and Murphy 1992). This fragment was synthesized in a
three-step PCR involving linear amplification.32
In the first step of PCR amplification, the extracellular domain of trKA (Primer 1 and
2) and the transmembrane and cytoplasmic domain (Primer 3 and 4) were amplified.
The primers were designed that the fragments could be hybridised in the second
PCR step. For this, the primer 2 from trKA (ED-trKA) consisted at its 3´end
sequences complementary to the 5´end sequence of TM-CPD-shrew-1 and
reversely, the primer 3 from TM-CPD-shrew-1 contained sequences complimentary
to the 3´end of ED-trKA. In this second amplification step, the fusion product trKA-
shrew GFP or BP was linearly amplified. This fragment was purified on agarose gel
and was reamplified in the third step using primers 1 and 4, the primer 4 was either
from GFP tag or from BP tag. The resulting product was cloned into pEGFP-N3
vector containing a GFP tag or into pcDNA 3.1(+) vector containing a BP tag.
The other expression constructs of shrew-1 and caveolin-1 were generated by
subcloning via PCR. All the clones were sent for sequencing to Sequiserve,
Vaterstatten and were analysed using Immunofluorescence, Western blot or by in
vitro translation.
TCD-shrew-1 ED-trKA ED-trKA TCD-shrew-1/GFP or BP
1. PCR amplification of ED-trKA and TCD of shrew-1/ GFP or BP
Primer 1 Primer 2 Primer 3 Primer 4
2. Linear amplification
ED-trKA TCD-shrew-1/ GFP or BP
3. Reamplification
Primer 1
Primer33
2.2.1.2.     RT-PCR analysis
To check for the presence of shrew-1 in different epithelial cell lines, RNA was
prepared using QIA-RNA midiprep kit (QIAGEN). This RNA was stored in a
precipitated form with 2 volumes absolute ethanol and 1/3 volume of 8M ammonium
acetate. From this RNA, 20 µg total or 1µg poly A(+) RNA was taken and was
centrifuged for 15 min at 15,000 rpm at 4ºC. The supernatant was removed and the
RNA was washed with 70% ethanol for 10 min at 15,000 rpm at 4ºC. The
supernatant was removed and the pellet was airdried and then dissolved in 12.5 µl
water and was vortexed well for 2min. To this pellet, 5 µl Oligo (d)T-primer(3uM) was
added and denatured for 10 min at 70°C and during this time vortexed 4 times. Kept
on ice and to this added:
6ul  5x reverse transcriptase
3ul  0.1M DTT
1.5ul  dNTP-Mix (10mM each)
This mixture was then incubated at 37°C for 2 min. To this was added 2ul M-MLV
Reverse Transcriptase (200 U/µl, Gibco BRL) and incubated at 37°C for 1 hour. The
enzyme was inactivated by incubation at 95°C for 5 min.
PCR amplification of this single-stranded DNA was done using primers from the
sequence of shrew-1 cDNA. As an internal control to detect for any genomic
contamination and to check the quality of the cDNA, primers from BiP, a
housekeeping gene were used.
2.2.2.      Protein Analysis
Protein analysis by SDS-polyacrylamide gel electrophoresis and Western blotting
were done as described previously (Kaufmann et al., 2000). For immunoblot
analysis proteins were transferred to nitrocellulose membrane (Hybond Amersham,
Germany) and further processed for detection using NBT/BCIP following the
manufacturers protocol (Roche). The commercial antibodies used are described
above in the materials section.34
2.2.2.1.     Generation of antibodies against shrew-1
Monoclonal antibodies were generated against shrew-1 in mice using the peptide
sequence NH2-ACMTLQTKGFTESLDPRRRIPGGVS–amide by Nanotools,
Teningen, Germany. The detection of endogenous protein in western blot was done
using a 1:20 dilution and in immunohistochemistry using a dilution of 1:10
Polyclonal antibodies were generated against the cytoplasmic domain of shrew-1 in
rats in collaboration with Genovac, Freiburg, Germany. The working dilution for the
western blot was 1:200 and for immunofluorescence a dilution of 1:100 was used.
2.2.2.2.   Protein interaction studies by in vitro binding assays using GST
fusion proteins
1.  Expression of recombinant proteins in Bacteria
Recombinant proteins were expressed in E.coli strain BL21 (DE3) pLysS as GST-
fusion proteins encoded by pGEX-5X1 vector into which the cDNA of the respective
protein was cloned. Expression and enrichment was done with glutathione
Sepharose beads (Pharmacia) according to the following protocol:
-  20 ml of LB Amp was inoculated with the respective plasmid and kept on
shaker overnight at 37ºC and 220rpm.
-  Added 180ml LB-Amp the next day and incubated again for 1h under the same
conditions.
-  Added 0.2mM IPTG in the medium to induce lac-promoter of the vector. The
shaking was further continued for approx. 3h.
-  All the further steps were performed at 4ºC with precooled solutions.
-  After the end of the incubation period, the bacteria were centrifuged at 4,000
rpm for 15 min and the pellet suspended in 5 ml NENT buffer containing 1mM DTT.
-  The cells were lysed by three repeated freeze and thaw cycles with snap
freezing in liquid nitrogen and thawing at 37ºC. After the last freeze and thaw cycle,
5µl of Benzonase (Merck) was added and incubated for 10min at 37ºC.35
-  The insoluble fraction consisting mainly of cellular debris was removed by
centrifugation at 12,000 rpm for 30 min.
-  The supernatant was mixed with 10% glycerol and was aliquoted into 1 ml
fractions and was stored at -80ºC.
2.  Purification of GST-Fusion proteins
Glutathione-Sepharose 4B Beads were washed in a 15ml falcon tube using NENT
buffer at 500rpm for 5 min. The beads were then stored at 4ºC in a 1:1 slurry with
NENT buffer. To a single aliquot of the bacteria extract, 20 µl of the beads were
added and were rotated at 4ºC on a rotor for 1h. The Glutathione-sepharose beads
bind with a very high affinity to the GST tag on the protein and formed an
immobilised complex which consisted only of the GST tagged protein bound on the
beads. This complex was then sedimented at 800rpm for 5 min and the supernatant
was discarded. The pellet was washed 3 times with 1 ml of NENT buffer (-DTT). The
washed pellet was then boiled with adequate volume of Laemmli buffer at 95ºC for 5
min and an SDS-PAGE was performed. The gel was finally stained with coomassie-
blue and was controlled for the protein expression and the quality of the purified
protein for further interaction studies.
3.  In vitro Transcription and Translation
For a pull down assay, it is required that one of the proteins used for testing the
interaction is purified on an immobilised substrate and the other exists in a
detectable form not necessarily immobilised. For this, the in vitro transcription and
translation of shrew-1-BP which was cloned into pcDNA 3.1(+) with a BP tag was
performed. This was done using in vitro Transcription and Translation system (TNT
®,
Promega). Radioactivity was incorporated into the shrew-1 protein by using 
35S-
methionine for easy detection of the protein using autoradiography. The procedure
was performed according to the manufacturers instructions.
4.  Pull down assay for testing protein-protein interaction36
To detect an in vitro interaction between two proteins, Glutathione-Sepharose 4B
beads coupled to the protein of interest were incubated with in vitro translated 
35S-
methionine labelled protein-in this case shrew-1. In case of an interaction, both the
proteins co-precipitated on the beads which could be detected by separating the
proteins by SDS-PAGE and detecting the radioactive protein by autoradiography.
The GST fused protein was immobilised on the beads by adding the Glutathione
Sepharose Beads and incubating on a rotor for 45 min in the cold room. After that,
the beads were blocked for 20 min with 20% skimmed milk powder dissolved in
NENT buffer. Beads were then washed twice with NENT buffer and once with TWB
(+1mM DTT) incubation buffer at 800 rpm for 5 min. 100 µl of TWB (+1mM DTT)
was added to the beads and to this 3-5 µl of the radioactively labelled translate was
added. The mixture was then incubated for 2h at RT or overnight at 4ºC.
The beads were then washed 5 times with NENT buffer at 1000 rpm for 5 min each.
The supernatant was discarded and the pellet was boiled with an adequate amount
of Laemmli buffer and loaded on an SDS polyacrylamide gel. The gel was then dried
and was subjected to autoradiography by which the 
35S labelled protein could be
detected in case of an interaction occurring between the two proteins. As a negative
control, the vector alone containing only the GST tag was taken.
2.2.2.3.  Analysis of in vivo interaction by coimmunoprecipitation
It is a method to detect complexing between different proteins. Cells were washed
twice with ice cold PBS and lysed for 30 min at 4
oC in  a buffer containing 10 mM
Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, and 60 mM n-octyl-
glucoside. Samples were precleared for 1 h at 4
oC using protein G-sepharose (20 µl,
1:1) and subjected to immunoprecipitation overnight at 4
oC using anti-GFP IgG (10
µl, mAb), anti-E-cadherin (5 µl, mAb 5H9), anti-Pan-cadherin (3 µl) and protein G-
Sepharose (30 µl, slurry 1:1). After 4-5 washes with the immunoprecipitation buffer,
samples were separated by SDS-PAGE (12% acrylamide) and transferred to
nitrocellulose. Immunoblotting was performed as described.37
2.2.3.      Eukaryotic cell culture
2.2.3.1.     Maintenance of cells
The cell lines MDCK, MCF7, Cos7, 12Z, EJ28 and RT112 were maintained in the
growth medium containing DMEM (Dulbeccos modified eagle medium) with 10%
FCS (Fetal calf serum) and 1% Penicillin-Streptomycin solution. The cell line PC12
was maintained in DMEM with 10% horse serum, 5% FCS and 1% penicillin-
Streptomycin solution. All these cell lines were kept in an incubator with 10% CO2
and 95-99% relative humidity at a temperature of 37°C.
2.2.3.2.     Induction of PC12 and MDCK cells
The PC12 cells containing trkA were induced using Nerve Growth Factor (NGF) at a
concentration of 100ng/ml. The effect was visible after 1h.
The MDCK cells were scattered using Scatter factor/Hepatocyte Growth factor
(SF/HGF) at a concentration of 20 ng/ml. A visible effect could be seen after 3h of
induction.
2.2.3.3.     Transfection  of Eukaryotic cells
Cos7, MCF7, RT112 and EJ28 and 12Z were transfected using PolyFect
TM.
SuperFect
TM was used for the transfection of 12Z cells, whereas Effectene
TM was
used for MDCK cell transfection. The procedure given in the manual from QIAGEN
was followed.
2.2.3.4.     Immunoflourescence of transfected cells
-The medium was removed from the cells and the cells were washed with 1x PBS.
-Cells were fixed on the cover slips using 4% Paraformaldehyde at room
temperature for 10 min.
-Cells were permeabilized using 0.2% Triton X (in PBS) for 10 min at RT.
-Blocked the cells using 10% FCS and 0.05% Na-Azide at least for 50 min.
-Added the primary antibody diluted with 10% FCS in PBS with 0.05% Na-Azide and
kept at RT for 1 hour.
-Washed the cells 3 times short and 3 times for 5 min with 1XPBS.38
-Added the fluorescent secondary antibody diluted like the primary antibody and kept
in dark at RT for 1 hour.
-Washed 3 times short with PBS and added DAPI for 5 min at RT.
-Washed 2 times for 5 min with PBS.
-Mounted the cover slips on a glass slide using flouromount.
-Dried at least for 60 min before observing under the microscope.
2.2.3.5.     Immunofluorescence with frozen sections
Was performed similar to the transfected cells except the fixation/permeabilization
was done with chilled methanol at -20ºC for 20 min.
2.2.3.6.     DAB staining (Immunohistochemistry) of tissue sections
-  Fixation was done with chilled methanol at -20ºC for 20 min
-  2x 5 min with 1XPBS
-  Blocked for 30 min at RT with 10% FCS/ 0.05% azide in 1x PBS
-  Washed 3x with TBS (0.05 M Tris pH 7.2-7.6 / 0.3 M NaCl/ 0.1% Tween 20)
-  Blocked for 5 min with peroxidase
-  Washed 3X short with TBS
-  Circled the tissue area with a fat marker
-  Incubated with primary antibody overnight at 4ºC
-  Washed 3x short and 3x 5 min each with TBS
-  Secondary antibody added for 30 min
-  Washed 3x short and 3x 5 min with TBS
-  Incubated with stain solution (1ml of bottle 3a+ 1 drop of bottle 3b) till stain 
precipitates
-  Washed with ddH2O and wiped out dry
-  Counter stained with Mayer´s Haematoxylin (2 min) (Sigma)
-  Washed 2x ddH2O
-  Slide was then mounted with flouromount39
2.2.3.7.     Generation of stable cell lines
To select for cells expressing the transfected constructs stably, Neomycin Sulfate-
G418 (Gibco BRL, Germany) was used for the selection process. The transfected
plasmids had neomycin resistance gene, so the cells, which had incorporated the
transfected plasmid into the genome, could survive the selection pressure, which
was applied by adding G418 into the medium. G418 was optimized at a
concentration of 0.6 mg/ml for MDCK cells and for MCF7 cells a concentration of 0.4
mg/ml was used.
2.2.3.8.     Lef-Luciferase reporter assay
MDCK cells stably expressing shrew-GFP or GFP alone were seeded in 6-well
plates at 300,000 cells/well. The following day, cells were transiently transfected
using the Effectene
® Transfection reagent (Qiagen, Hilden, Germany). For this, 0.4
µg of reporter gene plasmid DNA (TOPFLASH, FOPFLASH: Upstate
Biotechnologies, Lake Placid, USA; UAS-5x-tk-Luc: Baniahmad et al., 1995) was
used. Each transfection was carried out in triplicate. Luciferase activities were
measured 24 h after transfection using the Luciferase Assay System (Promega,
Mannheim, Germany).
2.2.3.9.     Permeablisation assay
For the antibody permeabilisation assay, MCF7 cells were transfected with shrew-1-
GFP and were grown till confluency. Cells were either fixed with 4% PFA or left
unfixed (living samples). IF was performed as described before.
2.2.4.     Confocal laser scan microscopy (CLSM)
Visualisation by CLSM was done as described before (Kaufmann et al., 2000).
Image processing of 3D-data sets was performed on a Silicon Graphics (Mountain
View, CA, USA)  (workstation using 'Imaris' Bitplane AG, Zurich, Switzerland) 3D
multi-channel image processing software (Messerli et al., 1993). Images were further
processed using Adobe Photoshop.40
2.2.5.     Surface biotinylation
The cell surface of confluent monolayers was labelled on ice with 0.5 µg/ml
membrane-impermeable EZ-Link Sulfo-NHS-Biotin (Pierce, Rockford, IL) in PBS, pH
9.0. After quenching (50 mM ammonium chloride in PBS, 0.1 mM CaCl2, 1 mM
MgCl2) the cells were lysed in 0.5 ml of RIPA buffer (150 mM NaCl,50 mM Tris pH
7.5, 0.25% sodium dodecyl sulfate, 0.1% Nonidet P-40) plus the protein inhibitor
cocktail Complete (Roche) for 10 minutes of incubation at 4ºC. Protein of each lysate
was used for precipitation (16h at 4ºC) with 30 µl of Neutravidin beads (Pierce). The
precipitates were washed as described previously (Rajasekaran et al., 1999) and an
immunoblot was performed (Kaufmann et al., 2000).41
3.      RESULTS
3.1.      Expression analysis of shrew-1 protein
Since no homology could be detected between shrew-1 and any other known
protein/domains, the characterization of this protein was started from the very
beginning.
3.1.1    Endogenous expression analysis
Two different types of antibodies were generated to analyse the endogenous
expression of shrew-1 at the protein level. First, custom-made mouse monoclonal
antibodies were produced against a synthetic peptide deduced from the putative
extracellular domain (for sequence see Materials and Methods). The resulting
monoclonal antibodies were first tested in tissue sections from pancreas and uterus
(Fig. 7A), since both these tissues were found to contain shrew-1 mRNA as shown
by Northern blot and RT-PCR analysis (Handrow-Metzmacher, unpublished).
Additionally, an immunoblot was performed with cell extracts from pancreas and
uterus (Fig. 7B, lanes 1 and 2, respectively). Both tissues were found to contain a
protein of approximately 45 kDa corresponding to the predicted size of the shrew-1
protein. Shrew-1 polyclonal antibodies raised in rats against the putative
cytoplasmic polypeptide sequence by genetic immunization (in collaboration with
Genovac, Freiburg, Germany) gave a signal of comparable size in these cell
extracts (Input, Fig. 7B; lane 7).
To test for the authenticity of the shrew-1 band detected in immunoblots,
immunoprecipitation (IP) was performed with monoclonal antibody and detection
with the polyclonal antibody and vice-versa (Fig. 7B; lanes 4-5; 7-8). In both the
cases a band of approx 45 kDa, the expected size of shrew-1 was detected. This
confirmed the specificity of the antibodies since both the antibodies were generated
against different peptides from the shrew-1 sequence.
But unfortunately, none of the antibodies seemed to detect endogenous shrew-1 in
the cell lines. Therefore, in further experiments shrew-1 was fused to a tag against
which antibodies were available.42
Figure 7. Shrew-1 antibody detects endogenous protein. (A)  To detect the endogenous protein,
pancreas and uterus cryosections were used and DAB staining was performed. Endogenous protein
(stained in brown) could be detected in parts of these sections. The small window at the bottom right
depict the secondary antibody control.(B) To check for the size of the protein, an immunoblot was
performed with these supernatants using cell extracts from pancreas and uterus (lane 1 and 2,
respectively). A protein of approximately 45 kDa was detected in both these cell extracts.
Immunoprecipitation  of endogenous shrew-1 from uterus cell extracts using shrew-1 polyclonal
antibody and detection with the monoclonal antibody and vice versa was done to confirm the
specificity of the shrew-1 band. Lane 4 depicts the input cell extract and lane 5 shows the
immunoprecipitated protein detected with the monoclonal antibody. Lane 7 depicts the input cell
extract and lane 8 depicts the immunoprecipitated protein detected with the polyclonal antibody.
Input is 10% of the total cell extract. Lanes 3 and 6 depict the marker proteins.
3.1.2.     Ectopic expression analysis
For performing experiments using ectopic shrew-1, its cDNA was cloned into two
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different expression vectors containing either a 10 aa long birch profilin tag (shrew-
1-BP) or a green fluorescent protein tag (shrew-1-GFP). To check whether these
vectors expressed the predicted open reading frame protein of 411 aa, shrew-1-BP
was translated radioactively in vitro using a reticulocyte lysate kit (see Materials and
Methods). SDS-PAGE and autoradiography revealed that shrew-1 could indeed be
translated in vitro to produce a protein of approximately 45 kDa (Fig. 8; lane 2). The
positive control used for in vitro translation was luciferase cDNA supplied by the
manufacturer (Fig. 8; lane 1). For detection of ectopic shrew-1, shrew-1-GFP was
transfected in MCF7 cells and the cell extracts were blotted with anti-GFP antibody
that detected a protein of the expected size of approximately 75 kDa in immunoblots
(Fig. 8; lane 3).
Shrew-1 polyclonal antibody raised in rats against the putative cytoplasmic
polypeptide sequence also gave a signal of comparable size in cell extracts of
MCF7 transfected with shrew-1-GFP (Fig. 8; lane 4). The polyclonal antibody also
detected ectopic shrew-1-GFP as shown in Fig. 8B. Shrew-1-GFP was transfected
transiently in MCF7 cells (Fig. 8B; a-c) and subsequent immunostaining was
performed with the preimmuniserum (PIS) (Fig. 8B; b) and with immune serum (IS)
raised in rats against shrew-1(Fig. 8B; d). The IS specifically detected the
ectopically transfected shrew-1-GFP as observed with the GFP autofluorescence.
Thus, the predicted shrew-1 aa sequence can translated in mammalian cells as
confirmed by antibodies raised against putative ORFs.
3.2.     Cellular localization of shrew-1
3.2.1.     Shrew-1 is an integral membrane protein
Shrew-1 fused to two different tags (to rule out the possibility that cellular
localization is affected by the tags) was used to determine the cellular localization of
the protein. These studies were performed in epithelial cell lines 12Z, RT112, EJ28
and MCF7 transiently transfected with shrew-1-GFP and shrew-1-BP. In all cases,
major pools of shrew-1 appeared to be localized at the plasma  membrane,
especially at the regions of cell-cell contact, irrespective of whether RT-PCR
(preliminary analysis) showed that the cell lines contained endogenous shrew-1,44
namely MCF7 and 12Z (Fig. 9A; a, d, e, h) or not, i.e. RT112 and EJ28 (Fig. 9A; b,
c, f, g).
Figure 8. Detection of ectopic expression. (A) shrew-1 was translated in vitro in the presence of
radioactive 
35S (lane 2) and was detected by autoradiography on SDS-PAGE. Lane 1 depicts the
positive control-Luciferase. Lane 3 shows shrew-1-GFP detected by a monoclonal antibody against
GFP and lane 4 depicts shrew-1-GFP detected by polyclonal shrew-1 antibody. Shrew-1-GFP was
transfected in MCF7 cells and the immunoblots were performed with the cell extracts from these
cells. (B) MCF7 cells transfected with shrew-1-GFP were stained with the polyclonal antibody against
shrew-1. Preimmune serum (PIS) was used as a specificity control. No signal could be detected with
the PIS (upper panel, b) but the immune serum (IS) detected a signal for the transfected protein
(lower panel, d).
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To analyse biochemically the presence of shrew-1 at the membrane, surface
biotinylation experiments were done. For this, membrane impermeable surface
biotin was used which binds to membrane proteins via its binding to primary amines.
The strong interaction between biotin and avidin was applied to pull down the
proteins bound to biotin at the membrane.
For this, neutravidin (a form of avidin) was coupled to agarose beads and these
beads were then added to the cell extracts containing biotinylated proteins.
Shrew-1-GFP was transiently transfected into MCF7 cells. Surface-exposed
proteins were then selectively  biotinylated using membrane-impermeable biotin.
After cell lysis and detergent solublization, biotinylated proteins were isolated by
incubation with agarose-coupled neutravidin beads. Immunoblotting using
antibodies against GFP revealed that shrew-1-GFP was present in the biotinylated
protein fraction (Fig. 9B; lanes 2-6) confirming that shrew-1 is an integral component
of the plasma membrane. E-cadherin, a transmembrane protein (Fig. 9B, lanes 8-
11) and pyruvate kinase, a cytosolic protein (Fig. 9B, lanes 13-16) were used as
positive and negative controls, respectively.
From these data it could be concluded that shrew-1 is a transmembrane protein with
at least a part of it exposed at the cell surface. Further studies in this direction were
done using MCF7 and MDCK cells since they are epithelial in nature and shrew-1
was isolated from an epithelial cell line and is found to be present mainly in tissues
of epithelial origin. Additionally, RT-PCR done with two different set of primers,
showed that shrew-1 mRNA is present in both these cell lines (Fig. 10).
3.2.2.     The carboxyl terminal of shrew-1 is cytoplasmic
To test the hypothesis that the putative carboxyl terminus of shrew-1 is cytoplasmic
(from computational analysis), permeabilisation studies were done. MCF7 cells
were transiently transfected with shrew-1 tagged with a C-terminal GFP tag (shrew-
1-GFP). One aliquot of the transfected cells was permeabilized (Fig. 11; a, b) and
immunodetection was performed using GFP antibody (Fig. 11; b, d) whereas the
other aliquot was not permeabilized (Fig. 11; c, d) and immunostaining was46
performed on live cells using GFP antibody in the presence of Sodium Azide to
prevent antibody-induced capping.
Figure 9. (A) Membrane localization of shrew-1. Shrew-1 tagged with GFP (shrew-1-GFP) or BP
(shrew-1-BP) was expressed in the eukaryotic epithelial cells: 12Z (human invasive endometriotic
cell line), RT112 (human bladder carcinoma cell line, non-invasive), EJ28 (human bladder carcinoma
cell line, invasive) and MCF7 (human breast carcinoma cell line, non-invasive). a-d show shrew-1-
GFP fluorescence and e-h show immunofluorescence signals using a mouse monoclonal antibody
against the BP tag visualized by a mouse-specific fluorochrome-conjugated secondary antibody. The
arrows indicate the expression of shrew-1 at cell-cell contacts.
(B) Cell surface biotinylation of MCF7 cells transfected with shrew-1-GFP. The biotinylated cell
surface proteins were pulled down with neutravidin-coupled beads. The proteins present in various
cell extract fractions were analysed by Western blots. Shrew-1-GFP was detected by anti-GFP
antibody (lanes 2-6). E-cadherin, a positive control protein, was detected by a monoclonal antibody
against E-cadherin (lanes 8-11) and Pyruvate kinase, a negative control cytosolic protein (lanes 13-
16), was detected with a monoclonal antibody. UCX: untransfected cell extract, CX: transfected cell
extract, sup: supernatant after pull-down of the biotinylated fraction, BF: pulled down biotinylated
fraction, C: control of neutravidin beads bound to non-biotinylated cell extract.
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The auto fluorescence from shrew-1-GFP (Fig. 11; a, c) could be seen in both
cases, but antibody staining could only be seen with cells that were permeabilized.
This clearly implies that the C-terminus is indeed cytoplasmic. A comparable result
was obtained when a similar experiment was performed in MDCK cells (preliminary
data). Unfortunately the orientation of the amino terminus could not be determined
due to the lack of antibodies against the amino terminus of the protein as well as
due to the fact that tagging shrew-1 at the amino terminus was not feasible since its
expression as an N-terminus could not be detected.
Figure 10. RT-PCR done with different primers from shrew-1 revealed the presence of shrew-1 in
both MCF7 and MDCK cell lines. Con.1 and Con.2 are the negative controls performed for the two
different primer sets. For primers, see Materials and Methods.
To overcome this problem, it was attempted to clone a small tag in shrew-1-GFP
after the putative signal peptide which was thought to be cleaved off and to perform
similar studies with this. Express tag comprising of 8 amino acids was selected for
this purpose and was cloned via linear amplification after approx. the first 50 amino
acids (aas), a region after the signal peptide which is composed of 43 aas. This
cloning was done in shrew-1-GFP which contains a GFP tag at the C-terminus. The
construct was called shrew-XP-GFP.
This construct was transfected transiently into MCF7 cells and the cells were either
permeabilized in one set or were kept non-permeabilized in the other set as shown
in Fig. 12. Anti-express antibody was used to detect this construct in permeabilized
(Fig. 12; a, b) and non-permeabilized (Fig. 12; c, d) cells but the expression was not
seen in either case. The autoflorescence from GFP could be detected in both the
cases (Fig. 12; a, c) leading to the conclusion that though the  construct is
expressed in a similar manner as the full length shrew-1, a tag added to the
ectodomain could not be detected (Fig. 12; b, d). This could mean that either the
ectodomain is secreted or that the confirmation of the protein does not allow the
exposure of the express tag to its antibody.
MCF7 MDCK      Con.1   Con.2 MCF7 MDCK      Con.1   Con.248
It was not possible to draw any conclusion about the orientation of the putative
ectodomain form the experiments performed till now. Further attempts were then
made to functionally characterise the transmembrane and cytoplasmic domains of
shrew-1.
Figure 11. Carboxyl-terminus of shrew-1 is cytoplasmic. Shrew-1-GFP transfected MCF7 cells were
permeabilised (a and b) or not permeabilised (c and d), as described in Material and Methods and
then subjected to immunofluorescence staining with anti-GFP antibody and Alexa 594-labelled
secondary goat anti-mouse antibody (b and d: red fluorescence). Intrinsic GFP fluorescence is green
(a and c). Shrew-1-GFP could be detected in permeabilised cells by immunostaining with anti-GFP
antibody (b) but not if the cells were not permeabilised (d).
3.3.     Fusion with trkA
Shrew-1 was fused with its transmembrane domain and the cytoplasmic domain to
the ectodomain of trkA. Tyrosine kinase A (trkA) is a receptor tyrosine kinase which
functions as a growth receptor and is activated after binding to its ligand-nerve
growth factor (NGF). After stimulation with its ligand, trkA gets phosphorylated at its
tyrosine residues via the carboxyl terminal to SHC, PI3 kinase, and PLCγ
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(Obermeier et al.,1994). Obermeier et al in 1996 fused the ectodomain of the
tyrosine kinase growth receptor trkA with the cytoplasmic domain of some other
tyrosine kinase receptors to characterise them via sending a signal for dimerisation
and activation through NGF (nerve growth factor) which is a ligand for trkA. This
served as a good system for studying the receptors without affecting the
endogenous situation. This concept was also used for shrew-1 to get an idea about
the physiological role of the cytoplasmic domain of shrew-1.
Figure12. Express tag fused between the putative signal peptide and the rest of the shrew-1-GFP
could not be detected in permeabilized (upper panel, a and b) or non-permeabilized (lower panel, c
and d) cells. MCF7 cells were transfected with shrew-XP-GFP (a-d). The autofluorescence of GFP
could be detected in both permeabilized (a) as well as non-permeabilized (c) cells.
This chimaera of shrew-1 and trkA was fused to two different tags, i.e. BP (trk-BP)
and GFP (trk-GFP) tag (Fig. 13A). The aim of these fusion constructs with different
tags was to control the induction of the cytoplasmic domain of shrew-1 via NGF and
look at the events and the morphological changes occurring in the cells.
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Figure 13. (A) Chimaera of trkA and the cytoplasmic domain of shrew-1 fused to BP or GFP tag. (B)
RT-PCR to test for the presence of endogenous trkA in MCF7, 12Z, EJ28 and RT112 cell lines. No
trkA band was detected at the expected size. GAPDH primers were used as an internal control for
the cDNA used. As a negative control for the primers, water was used instead of the template in the
reaction mixture.
Figure 14. Expression analysis of trkA and shrew-1 fusion constructs-trk-GFP or trk-BP in MCF7,
EJ28, 12 Z and RT 112 cell lines. Both trk-GFP (upper panel) and trk-BP (lower panel) localise at the
membrane concentrated at the cell-cell contact sites. Trk-GFP is shown as green fluorescence and
trk-BP as red fluorescence.
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It would be possible to cover two different aspects of shrew-1 function: (i) In the
direction of interaction partners-whether after stimulation with NGF some
conformational changes might occur in the cytoplasmic domain of shrew-1 which
might induce it to interact with some other proteins and (ii) If the cells behave in a
similar way as shown earlier for other fusions of trkA with other tyrosine kinase
growth receptors, it could imply that shrew-1 is also a member of the tyrosine kinase
receptor family.
trk-BP and trk-GFP were transfected into different cell lines namely MCF7, EJ28,
RT112 and 12Z. These cell lines were tested by RT-PCR (RT-PCR) for endogenous
trkA expression. trkA was found to be absent in these cell lines (Fig. 13B). The
expression analysis of trk-BP and trk-GFP showed their presence at the cell-cell
contacts in a similar way as shrew-1 (Fig. 14). There was obviously no change in
cellular localization compared with full length shrew-1.
Furthermore, NGF was added at a concentration of 100 ng/ml to induce trkA and
the effect was monitored after 24 h. As expected, PC12 cells containing
endogenous trkA responded to the stimulus by scattering and the cells exhibited a
totally different morphology in which they became more flattened and developed
protrusions. On the other hand, other epithelial cells transfected with the fusion
constructs showed no change in behaviour. To rule out the possibility that this was
due to low transfection efficiency, cells were stably transfected with the fusion
constructs by selecting for the respective plasmid using G418. The selection
pressure was applied for approximately two weeks. Only 40% of MCF7 cells were
found to stably express trk-BP and trk-GFP. On inducing these cells with NGF still
no effect could be seen.
Since no scattering behaviour or any other morphological effect was observed, it
could be concluded that the fusion of shrew-1 with trkA had no effects on its
functioning or behaviour in the cells. From these experiments the possibility that
shrew-1 is a growth receptor of the tyrosine kinase family could be ruled out. Further
experiments were then done in the direction of the characterisation of shrew-1 at the
membrane as an integral component of the membrane.52
3.4.    Localisation of shrew-1 at the basolateral part of the membrane and its
complexing with E-cadherin-β-catenin complexes in polarised cells
3.4.1.     shrew-1 as a component of Adherens junctions
In most of the cases, the targeting of the membrane proteins in polarised cells is
quite specific, they target either to the apical or the basolateral compartment of the
membrane. To check whether shrew-1 targeted to the apical or basolateral domain
of the plasma membrane, shrew-1-GFP was transfected into MDCK cells which
were polarised by growing on transwell membrane filters. MDCK cells are a known
model for polarised cells in which the specific sorting of the protein to the apical or
basolateral compartments can easily be seen (Stegmaier et al., 2000). Confocal
analysis of these cells along the xz-axis revealed shrew-1 to be present
predominantly at the basolateral compartment of the membrane (Fig. 15 A, lower
panel).
Since it is well-known that the basolateral part of the membrane is rich in adherens
junctions, a marker for adherens junctions was used for testing the co-localisation of
shrew-1 with another protein of these junctions. E-cadherin is a well-known protein
of these junctions and plays an important role in maintaining their stability (see
Introduction). Optical sectioning with confocal microscopy revealed that shrew-1 and
E-cadherin colocalise at membrane especially at the regions of cell-cell contacts-
observed both in xy- and xz-axis (Fig. 15; B and C).53
Figure 15. shrew-1 is localised to the basolateral part of the plasma membrane and colocalises with
E-cadherin.  (A) MDCK cells expressing shrew-1-GFP were grown on transwell filters. Confocal
microscopy was done along the xy- and xz- axis that revealed shrew-1 to be present on the
basolateral part of the membrane. (B) Colocalisation of shrew-1 with E-cadherin at the intercellular
junctions. (C) Detailed analysis of physical colocalisation of shrew-1 and E-cadherin by confocal
microscopy.Shrew-1-GFP is shown in green and endogenous E-cadherin staining is recorded in red.
3.4.2.   shrew-1 complexes with cadherin-catenin complexes specifically in
polarised cells
Whether this colocalisation was the result of shrew-1 interacting specifically with E-
cadherin or just a coincidence was further investigated by doing in vivo interaction
assays. MCF7 cells were transiently transfected with shrew-1-GFP or the vector
(GFP) alone and grown to confluency.
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Figure 16. Interaction between shrew-1 and E-cadherin as shown by coimmunoprecipitation.  (A)
MCF7 cells transfected with shrew-1-GFP (lanes 1, 3) or with GFP (lanes 2, 4) were subjected to
immunoprecipitation with anti-GFP. First, 10% of the total cell extract (Input) was immunoblotted (IB)
with anti-GFP  (upper panel) and anti-E-cadherin plus anti-β-catenin (middle panel) antibodies.
Coimmunoprecipitations (Co-IP) were performed with anti-GFP antibody and the immunoprecipitates
subjected to immunoblotting with anti-E-cadherin then anti-β-catenin antibodies (lanes 3, 4). (B) In
the reverse experiment, the cell extracts from MCF7 cells transfected with GFP (lanes 1, 3) or shrew-
1-GFP (lanes 2, 4) were subjected to immunoprecipitation (IP) with anti-E-cadherin antibody. Input
panels depict 10% of the cell extracts immunoblotted with anti-GFP antibody (upper panel), or
endogenous E-cadherin protein immunoblotted with anti-E-cadherin antibody (lower panel).
Coimmunoprecipitations (Co-IP) were performed with E-cadherin antibody, and shrew-1 was
detected by immunoblotting with anti-GFP antibody as seen in lane 4. CX denotes the total cell
extract.
Cell extracts were prepared and transfection efficiencies were monitored by
Immunoblotting (IB) 10% of the total cell extract using GFP antibody (Fig. 16 ; A and
B; Input). The remaining cell extract was immunoprecipitated (IP) with GFP
antibody, the immunoprecipitated complex was then immunoblotted using E-
cadherin  antibody (Fig. 16A; lanes 3, 4). E-cadherin could be detected in the
immunocomplex pulled down by monoclonal anti-GFP antibody. β-catenin was also
detected on reprobing the same blot with the beta-catenin antibody (Fig. 16 A; lane
3 and 4)
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The reverse experiments confirmed the same results when IP was done with E-
cadherin antibody and shrew-1-GFP could be detected in the same complex (Fig.
16B; lane 3 and 4).
An interesting observation made during these experiments was that no complexing
between shrew-1 and E-cadherin was observed when the cells were not confluent
(preliminary data). This could possibly mean that the cells need some mature
junctions to stabilise this complexing (see Discussion).
Figure 17. Coimmunoprecipitation of N-cadherin and shrew-1-GFP. EJ28 cells were transfected with
GFP (lanes 1, 3) or shrew-1-GFP (lanes 2, 4). Input shows 10% of the total cell extracts (lanes 1, 2).
Immunoprecipitation (Co-IP) was performed with GFP-antibody (lanes 3, 4). Immunoblotting was
performed with antibodies against GFP, N-cadherin and β-catenin. No interaction of shrew-1 with N-
cadherin and β-catenin was observed.
Furthermore, the ability of shrew-1 to interact with cadherins in epithelial cell lines
that are unable to form adherens junctions (for example EJ28 cells, an invasive
human bladder carcinoma cell line expressing N-cadherin) was analysed. EJ28 cells
were transfected with shrew-1-GFP and GFP alone and the cell extracts were
prepared in a suitable lysis buffer (see Materials and Methods). Monoclonal anti-
GFP antibody was used for Co-IP assays performed as described above and the
bound proteins were pulled down which were further subjected to SDS-PAGE and
immunoblotted with anti-N-cadherin, anti-β-catenin and anti-GFP antibodies.
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10% of the total cell extract prepared in the beginning was kept as input. The
transfected proteins (shrew-1-GFP and GFP alone), N-cadherin and β-catenin could
be detected in the input lanes (Fig. 17; lanes 1and 2) but no N-cadherin or β-catenin
could be detected in the immunoprecipitated fraction (Fig.17; lanes 3 and 4). Only
shrew-1-GFP and GFP alone could be seen (Fig. 17; lanes 3 and 4) which reflected
that the immunoprecipitation functioned.
These data reiterate that shrew-1 can interact with cadherin-catenin complexes in
junctions of polarised epithelial cells but not with cadherin-catenin complexes (here
N-cadherin) in non-polarised cells.
3.4.3.     Direct interaction of the cytoplasmic domain of shrew-1 with β-catenin
The results shown so far did not indicate whether the interaction between E-
cadherin and shrew-1 is due to direct binding of the proteins or is caused by an
intermediate protein such as a scaffolding protein in the complex (β-catenin being a
candidate).  in vitro pull-down assay between the cytoplasmic domain (CPD) of
shrew-1 (used as GST fusion protein) and in vitro translated β-catenin was done.
For this, β-catenin was translated radioactively in vitro (Fig. 18; lane 1) and was
incubated with GST alone (lane 3 ) or GST fused to CPD of shrew-1 (GST-CPD-
shrew-1, lane 4), purified from bacterial cell extracts (see Materials and Methods).
Figure 18. Direct interaction of β-catenin with the cytoplasmic domain of shrew-1 (GST-CPD-shrew)
in an in vitro pull-down assay. Full-length β-catenin was translated in vitro using 
35S
 methionine. GST
and GST-CPD-shrew were purified on glutathione sepharose beads, then incubated at RT for 1 h
with radioactively labelled β-catenin. After washing the beads, samples prepared as described in
Material and Methods were subjected to SDS-PAGE and autoradiography. Lane 1: radioactive β-
catenin as input, lane 2: the marker, lane 3 : GST alone with β-catenin and lane 4: GST-CPD-shrew
with β-catenin.
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The beads were then washed, bound proteins were subjected to SDS-PAGE and
subsequently autoradiography was done to detect the radioactively translated
protein bound to GST-CPD-shrew-1.
As expected, no signal could be seen in the lane with GST alone incubated with the
radioactive proteins (Fig. 18; lane 3). β-catenin could be detected in the lane with
GST-CPD-shrew-1 (Fig. 18; lane 4), thus leading to the conclusion that β-catenin
interacted with the cytoplasmic domain of shrew-1 in vitro as a direct interacting
partner.
In similar studies done with GST-CPD-shrew and full length E-cadherin, no
interaction could be observed between shrew-1 and E-cadherin (preliminary data).
Taken together, these data support the idea that shrew-1 interacts via its
cytoplasmic domain with β-catenin but not with E-cadherin in adherens junctions.
However, this does not exclude that shrew-1 binds to other as yet unidentified
components of the adherens junctions.
3.5.  Disruption of adherens junctions via addition of scatter factor/hepatocyte
growth factor (SF/HGF) does not affect the colocalisation of shrew-1 and E-
cadherin
The experiments done till now showed that E-cadherin and shrew-1 colocalise at
the adherens junctions regardless of the maturity of the junctions, albeit do not
complex with each other when the junctions are not mature. This was observed
during the in vivo pull down assays when MCF7 cells were used which were not
completely confluent. In continuation with this, it now became important to check
whether this colocalisation persisted even after the disruption of the cellular
junctions. To this aim, a physiological stimulus, scatter factor/hepatocyte growth
factor (SF/HGF) was applied to the MDCK cells transiently transfected with shrew-1-
GFP.
SF/HGF is a known cytokine that acts as a morphogen leading to epithelial-
mesenchymal transitions. It is known to disrupt E-cadherin mediated junctions in
MDCK cells through activation of its receptor c-met. During disruption, E-cadherin is58
transiently transported into recycling vesicles reported to contain caveolin-1 (Akhtar
and Hotchin, 2001).
MDCK cells transiently transfected with shrew-1-GFP were seeded at very low
density on cover slips and were grown till the formation of islands. SF/HGF was
added at a concentration of 20 ng/ml and the effect was monitored on cover slips
from  the same culture dish at 0h, 4h, 8h and 15h. After 8h a drastic change in the
intracellular distribution of shrew-1 was observed (Fig. 19).
Figure 19. Effect of scatter factor (SF) on MDCK cells. MDCK cells transfected with shrew-1-GFP
were seeded at very low density on cover slips and were grown till formation of small colonies.
SF/HGF was added at a concentration of 20 ng/ml to these cells. The effect was monitored on cover
slips from  the same culture dish at 0h, 4h, 8h and 15h. After 8h, cell-cell contacts were disrupted but
colocalization of shrew-1-GFP (green) and endogenous E-cadherin (red) could also be seen in
cytoplasmic vesicles. After 15h shrew-1-GFP and endogenous E-cadherin colocalised again
predominantly at the plasma membrane.
After 15h
After 4h 0 h
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GFP fluorescence at the plasma membrane was reduced whereas intracellular
particulate structures were labelled, which also stained for E-cadherin (marked with
arrow heads). When the scattering effect of SF/HGF was gone after fifteen hours,
GFP fluorescence and E-cadherin were again prominent at the plasma membrane.
These results suggest that upon disruption of junctions by a physiological stimulus
shrew-1 is translocated together with E-cadherin to intracellular vesicles. Although it
seems from these experiments that shrew-1 and E-cadherin have a comparable
pattern of internalization, it can however not be discriminated whether this is caused
by a weak interaction not detectable by coimmunoprecipitation or simply by a similar
response to stimulation by SF/HGF.
3.6.     Shrew-1 and caveolin-1
Taking into account the facts that i) shrew-1 is an integral component of E-cadherin-
β-catenin complexes with which caveolin-1 also interacts and ii) Shrew-1 also
colocalises with E-cadherin in the same vesicles coated with caveolin-1 during
junctional disruption, it was worth checking the association of shrew-1 with
caveolin-1.
For this, localisation studies of shrew-1-GFP and endogenous caveolin-1 were
performed using CLSM. It was seen that both the proteins colocalise strongly at the
membrane (Fig. 20). Whether this colocalisation also leads to any complexing of
shrew-1 with caveolin-1 or not was checked by in vivo pull down assays. For this,
shrew-1-GFP was transfected transiently in MDCK cells containing endogenous
caveolin-1 and cell extracts were prepared. 10% of the total cell extract was kept as
input to control the efficiency of transfection. Caveolin-1 polyclonal antibody was
used to pull down caveolin-1 and the associated proteins. SDS-PAGE and
subsequently an immunoblot was performed. Shrew-1-GFP could be detected in the
input (Fig. 21A; lane 3) and in the immunoprecipitated fraction (Fig. 21A, lane 1).
Fig. 21A, lane 2 depicts the immunoprecipitated fraction of GFP alone which is the
negative control.60
Figure 20. Colocalisation between shrew-1 and endogenous caveolin-1 in MDCK cells. shrew-1-GFP
was transfected in MDCK cells which were immunostained for endogenous caveolin-1. Confocal
analysis showed colocalisation of shrew-1 and endogenous caveolin-1 predominantly at the
membrane. Shrew-1-GFP staining is shown as green, caveolin-1 staining is seen as red and the
overlay between caveolin-1 and shrew-1 is seen as yellow
To test the direct interaction between two integral membrane proteins by a pull
down assay is normally not possible since it is quite tedious to express a membrane
protein in bacteria, due to the strongly hydrophobic transmembrane domain which
affects the proper folding of the protein. Caveolin-1 as an exception can be
expressed as a GST fusion protein in bacterial cells due to the reasons that it exists
as a soluble form and secondly, both its N- and C-terminal are cytoplasmic, so it
does not undergo all the modifications of integral membrane proteins (Li et al.,
1996). Taking an advantage of this situation, a pull down assay was performed
between radioactively labelled full length shrew-1 (Fig. 21B; lane1) and GST fused
caveolin-1 (GST-cav). 
35S coupled shrew-1 was incubated with glutathione beads
containing purified GST alone or GST-cav. SDS-PAGE and autoradiography were
done with the beads after washing them a few times with suitable buffer (see
Materials and Methods) to remove non-specific proteins from the complex.
Radioactive shrew-1 was detected in the complex with GST-cav (Fig. 21B; lane 3)
but not with GST alone (Fig. 21B; lane 2).
From this data it could be concluded that shrew-1 interacts directly with another
protein of E-cadherin-β-catenin complex, i.e. caveolin-1. The interaction of shrew-1
with two key players of invasiveness suggests that it might have a role to play in this
process but the mechanism is still unclear.
Shrew-1-GFP Caveolin-1 Overlay 61
Figure 21. Shrew-1 and caveolin-1 interact in vivo and in vitro.  (A) Caveolin-1 was
immunoprecipitated using a polyclonal caveolin-1 antibody from MDCK cell extracts transfected with
GFP or shrew-1-GFP. 10% of the total cell extract was kept as input. Shrew-1-GFP was detected in
the input fraction (lane 3) as well as in the immunoprecipitated fraction (lane 1) when an immunoblot
was done with anti-GFP antibody. The negative control containing GFP alone (lane 2) was empty.
(B)  Direct interaction between shrew-1 and caveolin-1 was shown by in vitro pull down assay.
Shrew-1-BP was translated in vitro in the presence of 
35S. GST alone and GST-caveolin-1 were
purified on Protein-G-Sepharose beads and then incubated at RT for 1 h with radioactively labelled
shrew-1. After washing the beads, samples prepared as described in Materials and Methods were
subjected to SDS-PAGE and autoradiography. Lane 1: radioactive shrew-1 as input, lane 2 : GST
alone with shrew-1 and lane 4: GST-cav with shrew-1.
3.7.     Shrew-1 overexpression studies
3.7.1.     Shrew-1 overexpression confers an invasive phenotype on cells
To analyse for the function of a protein, it is necessary to downregulate it or
overexpress it. In this direction, shrew-1 was overexpressed in cells by making
stable cell lines. For this, shrew-1-GFP was transfected transiently into MDCK cell
line which was then put under a selection with G418 for about 2 weeks. After two
weeks, different clones could be seen which probably arose from a single cell.
These clones were then isolated using silicon cloning rings and were further
propagated and analysed. Most of the clones died in a few days, only a single clone
survived. With the vector alone, there were more clones that survived this selection
giving us the first hint that high concentrations of this protein might be toxic for the
cells.
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This single clone from shrew-1-GFP and the clones from GFP were analysed. The
cells stably overexpressing shrew-1 showed a totally changed behaviour, they were
very easily trypsinised and had a different morphology from normal MDCK cells. The
typical honey-combed morphology of the cells was lost and the membrane had a very
ruffled appearance. Immunostaining for E-cadherin and β-catenin was done in these
cells. Both E-cadherin and β-catenin showed a fuzzy appearance at the membrane
(Fig. 22; b and c; e and f). The confocal analysis of these cells also showed the
presence of these membrane proteins partially in the cytoplasm as well, which is quite
different from normal MDCK cells expressing E-cadherin and β-catenin (Fig. 22; a and
d). These observations pointed towards the fact that the adherens junctions are
disrupted and the cells seem to have lost the property of contact inhibition which is
quite important to keep the cell in a non-invasive stage to confirm these observations,
matrigel invasion assay was performed to check whether the cells are invasive or not
or is it just an altered phenotype.
For the matrigel invasion assay, transwell filters coated with matrigel derived from
components of the extracellular matrix were taken. Under normal conditions, it is not
possible for MDCK cells to invade through this gel since they lack MMPs which are
secreted only when the cells are invasive. The MMPs are essentially a feature of
tumour cells where they are needed to spread and invade other tissues by digesting
the extracellular matrix.63
Figure 22. Shrew-1 stable cell line shows a completely altered phenotype. MDCK cells stably
transfected with shrew-1-GFP showed a different staining of E-cadherin (c) and β-catenin (f). The
regular pattern of endogenous E-cadherin (a) and endogenous β-catenin (d) expression seems to be
completely altered. (b) and (e) show the staining of shrew-1-GFP in the stable cell line. a and d are
wild type MDCK cells expressing E-cadherin and β-catenin, respectively.
As a control, transwell filters without any matrigel were taken to estimate the motility
of the cells. the cells that have acquired a motile behaviour travel faster through
these filters.
MDCK cells stably transfected with GFP and shrew-1-GFP were seeded on matrigel
coated filters (Fig. 23A) as well as filters without any matrigel (Fig. 23B) and were
grown for 72h till completely dense.
After 72h, the cells were fixed and subsequently DAPI was put on the cells to label
the nuclei. The filters were then transferred to glass slides which were then viewed
under the microscope. The number of cells on the lower surface of both the filters
was counted in different fields. The invasive fold of the cells was finally counted as
number of invasive cells/motile cells x 100. Untransfected cells were used as
background control. The invasion fold was found to be increased by almost 12-fold
as compared to the 3-fold increase of invasiveness in the vector control.
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Figure 23. Shrew-1 stable cell line is invasive as shown in a matrigel invasion assay. Invasion assay
was done by seeding MDCK cells stably overexpressing shrew-1-GFP, GFP and untransfected cells
on transwell filters coated with matrigel (upper panel, A). The number of cells invading the matrigel
were counted by counting the cells on the lower side of the filter after 72h. As a control, the cells
were seeded in parallel on uncoated transwell filters (B). The motile cells that could cross these
filters were counted. This was done in a set of three independent experiments and the mean values
were take. Invasion index was counted as the total number of invasive cells/ total number of motile
cells x 100.
From this data, it could be concluded that stable overexpression of shrew-1 in wild
type MDCK cells confers an invasive phenotype on these cells. One could
hypothesise from this observation that the stoichiometry of shrew-1 is important for
the maintenance of adherens junctions and hence contact inhibition of the cell and
when this is disturbed, the cell becomes invasive. The deregulation of shrew-1
seems to be the key behind this mechanism. Taken together the data that shrew-1
is also present in normal epithelial tissues such as kidney and pancreas, it could be
said that shrew-1 is important for the normal epithelial cells but when it is
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deregulated, the epithelial cells lose their normal phenotype. Hence the regulation of
shrew-1 seems to work in a spatio-temporal manner.
3.7.2.  Shrew-1 overexpression leads to stabilization and activation of β-
catenin in untransformed MDCK cells
Looking closely at the costaining between shrew-1-GFP and β-catenin in the stable
cell line (Fig. 24A), it could be seen that shrew-1 and β-catenin colocalize in the
membrane as well as in cytoplasm which is normally not the case for either of the
two proteins. This is only the case when β-catenin is stabilised in the cytoplasm, not
being able to be degraded. This excess β-catenin travels to the nucleus, forms a
complex with Tcf/Lef and subsequently binds to the Tcf/Lef promoter which further
leads to transcription of various oncogenes such as c-myc and the cells become
invasive (see Introduction).
To test this, pTOP and pFOP plasmids were used. pTOP plasmids contain the
binding sites for Tcf/Lef in triplicate and when activated β-catenin comes and binds
to these sites, transcription is initiated which leads to the activation of luciferase
reporter which is also present in this plasmid. Hence the activation of the reporter by
β-catenin can be measured in relative light units (rlu). On the other hand, pFOP
plasmid has the same sequence except that the Tcf/Lef binding sites are mutated in
the plasmid. It is used as a control to check non-specific activation of some other
elements in this reporter which might lead to luciferase activity.
pTOP and pFOP plasmids were transfected into untransfected MDCK cells (for
background), GFP stables and into shrew-1-GFP stables. The next day cell extracts
were prepared in a suitable lysis buffer (see Materials and Methods) and the activity
was measured in a luminometer. The pTOP Flash activity in shrew-1-GFP stable
cell line was found to be increased by 150-fold as compared to GFP stable cell line
(Fig. 24B). This showed that β-catenin is present in an activated form in this shrew-1
stably transfected cell line which also showed an invasive phenotype. This clearly66
points to the fact that a high amount of shrew-1 somehow deregulates the stability
of the adherens junctions as well as leads to activation of β-catenin in a normal
untransformed cell line thus generating an invasive phenotype. Whether this
activation of β-catenin also affects the other components of the Wnt signaling
pathway still has to be deciphered.
Figure 24. Overexpression of shrew-1 leads to activation of β-catenin in MDCK cells. (A) Altered
expression of β-catenin in shrew-1 stable cell line could be seen. The presence at the membrane
was not so prominent and additionally it seemed to colocalise with shrew-1 in the cytoplasm. Shrew-
1 staining is shown as green, endogenous β-catenin staining is red and the overlay is seen as yellow
where the nuclei are also stained with Hoechst dye. (B) pTOP FLASH assay with shrew-1 stable cell
line. pTOP and pFOP plasmids were transfected into GFP and shrew-GFP stable cell lines and the
activity of the luciferase reporter was measured. pTOP activity was approximately 150-fold higher in
the shrew-1-GFP stable cell line compared to the GFP stable cell line. Luciferase activity is
measured as relative light units (RLU). There was no marked change in pFOP activity.
pTOP-Flash
0
50000
100000
150000
200000
250000
300000
GFP-TOP GFP-FOP Shrew-
TOP
Shrew -
FOP
L
u
c
i
f
e
r
a
s
e
 
A
c
t
i
v
i
t
y
Shrew-1 Beta-catenin
A
B67
 3.8.     Mapping of the interaction domain of shrew-1
3.8.1.     Cellular localization of shrew-1 deletion constructs
To further characterise shrew-1, different domains of shrew-1 were cloned into the
eukaryotic expression vector containing GFP tag. The ectodomain, the ectodomain
with the transmembrane domain, the cytoplasmic domain and the cytoplasmic
domain with the transmembrane domain were all fused with the C-terminus GFP tag
(Fig. 25A). To study the cellular localisation of these domains, these plasmids were
transfected transiently into MCF7 cells
GFP Ectodomain SP GFP Ectodomain SP
GFP Ectodomain SP TD GFP Ectodomain SP TD Ectodomain SP TD
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Figure 25. Deletion constructs of shrew-1. (A) Scheme of the deletion constructs made from different
domains of shrew-1-all fused to GFP tag at the C-terminus. Ectodomain of shrew-1 (ED-GFP),
ectodomain and the transmembrane domain of shrew-1 (NTD-GFP), transmembrane domain and the
cytoplasmic domain of shrew-1 (TCD-GFP) and the cytoplasmic domain of shrew-1 (CPD-GFP). (B)
Cellular localisation of shrew-1 deletion constructs –ED-GFP, NTD-GFP, TCD-GFP and CPD-GFP in
MCF7 cells. (C) Biotinylation of TCD-GFP and NTD-GFP in MCF7 cells. Input is 10% of the total cell
extract. Sup is the supernatant that contains no biotinylated protein and Bio is the biotinylated
fraction bound on neutravidin beads. An immunoblot was done with the input, supernatant and the
biotinylated fractions. The primary antibody used was monoclonal anti-GFP antibody and the
secondary antibody was coupled to alkaline phosphatase.
and the expression was observed under the confocal microscope. It was seen that
the ectodomain of shrew-1 (ED-GFP) could not be expressed alone or was
degraded (as seen in Fig. 25B) which was not surprising since this effect was also
seen in bacteria and could be attributed to the presence of the low complexity
region in the ectodomain (discussed later).
On the addition of the transmembrane domain to the ectodomain (NTD-GFP), the
construct was clearly expressed (Fig. 25B), mainly in the perinuclear space but
visibly very less at the membrane. This result was quite perplexing considering the
fact that both the signal peptide and the transmembrane domains which are usually
responsible for targeting of the proteins to the membrane were present in this
construct (discussed later).
Proceeding with the other constructs, the cytoplasmic domain (CPD-GFP) was
transfected into MCF7 cells and it showed an expected expression in the cytoplasm
as well as a strong expression in the nucleus (Fig. 25B) which could also perhaps
be due to its small size due to which it could simply diffuse into the nucleus. The
addition of the transmembrane domain to the cytoplasmic domain (TCD-GFP) lead
to a drastic change in the localisation of this construct, the major part being present
at the membrane similar as full length shrew-1 and some part in the perinuclear
space (Fig. 25B). It could be concluded from this expression analysis that in addition
to the transmembrane domain, some amino acids from the cytoplasmic domain are
also responsible for the targeting of the protein to the membrane (personal
communications, Gisbert Schneider).69
Figure 26. Characterisation of NTD-GFP and TCD-GFP. (A)  semi-stable MDCK cell line was
generated using NTD-GFP and the cellular localisation was analysed. In vivo interaction assay with
E-cadherin was performed for which monoclonal anti-GFP antibody was used for IP and anti-E-
cadherin as well as anti-GFP antibody were used for IB. 10% of the total cell extract was kept as
input. The input fraction contained E-cadherin and NTD-GFP. The IP fraction contained NTD-GFP,
IgG and a small amount of E-cadherin. (B) TCD-GFP stable line was also analysed for cellular
localisation and for complexing with E-cadherin as done above. The input fraction contained E-
cadherin and TCD-GFP. The immunoprecipitated fraction contained TCD-GFP, IgG and a
comparably larger amount of E-cadherin.
Biotinylation studies were then performed with NTD-GFP and TCD-GFP since only
these two constructs showed a clear association with the membrane, the CPD being
present in the cytoplasm and the perinuclear space and the ED-GFP being
degraded. For this, NTD-GFP and TCD-GFP were transfected in MCF7 cells and
biotinylation was performed as described previously (also see Materials and
Methods). Quite interestingly it was seen that that NTD-GFP was biotinylated very
Input    IP
Input     IP
E-cadherin
E-cadherin
IgG
IgG
TCD-GFP
NTD-GFP
NTD-GFP
TCD-GFP
B
A70
clearly (Fig. 25C, upper panel) whereas TCD-GFP was not biotinylated as strong as
NTD-GFP (Fig. 25C, lower panel), inspite of the fact that the membrane expression
of TCD-GFP was much stronger as compared to NTD-GFP. The explanations
behind it could be that in case of TCD-GFP, the protein is transported to the
membrane, associates to it probably via its transmembrane domain and is stabilised
because of the amino acid residues from the CPD but since no part is present really
at the surface, there are no amino acids available for biotin to bind. In case of NTD-
GFP one could speculate that there are amino acids available to bind but the
membrane associated form is not very stable and perhaps is in a state of
continuous equilibrium since it cannot be seen expressed at the membrane in
immunofluorescence.
3.8.2.     Complexing with E-cadherin
Along these lines, these constructs were expressed in polarised MDCK cells and
the cells were put under a selection pressure with G418 for two weeks.
Approximately, 25% of the cells were shown to stably express NTD-GFP (Fig. 26A)
and TCD-GFP (Fig. 26B). The expression observed in MCF7 cells was reproduced
except for the fact that a stronger membrane association of TCD-GFP was
observed and the staining initially observed in the perinuclear space had
disappeared.
To check for the complexing  of these domains with E-cadherin,
coimmunoprecipitation analysis was done with these MDCK cells. Cell extracts were
prepared to which anti-GFP antibody was added to pull down the GFP tagged
constructs-NTD-GFP and TCD-GFP. 10% of the total cell extract was kept as input.
Protein-G-Sepharose beads were added to the extract to immobilize the antibody-
protein and the other interacting proteins complex. An immunoblot was done with
anti-GFP antibody to detect the GFP tagged protein in the input as well in the
immunoprecipitation to detect whether the protein has been immunoprecipitated or
not. The GFP antibody detected bands for both NTD-GFP (Fig. 26A) and TCD-GFP
(Fig. 26B). In input as well as in IP fraction lanes. Anti-E-cadherin antibody was
used to probe the blot to detect whether these deletion constructs complexed with
E-cadherin or not. Both of these constructs complexed with E-cadherin but TCD-71
GFP showed a more strong complexing as compared to NTD-GFP. One thing that
was clear from this result was that the transmembrane domain plays an important
role in this complexing but the stabilisation provided by the amino acids form the
cytoplasmic domain leads to a stronger and perhaps a more stable association
between shrew-1 and E-cadherin.72
4.     Discussion
4.1.     Validation of shrew-1 mRNA and protein
Two alternatively spliced messages have been identified for shrew-1, a 4 kb
message from the invasive passages of the endometriotic cell line-EEC145T and a
9 kb mRNA from the brain. Although the 4 kb isoform was detected in various other
tissues such as kidney, spleen and pancreas, the 9 kb isoform was specifically
present in brain in addition to the 4 kb isoform (Handrow-Metzmacher, unpublished).
The longest cDNA that could be isolated was 2910 bp in size, which encodes an
open reading frame (ORF) of 411 amino acids that corresponds to a protein of 45
kDa, shrew-1.
Supporting the isolation of shrew-1 from an invasive cell line, ESTS were isolated
from carcinomas such as colon carcinomas that corresponded to shrew-1 cDNA
sequence. Recently, another group has identified a cDNA, MOT8 that is identical in
sequence to shrew-1, from an invasive fibrosarcoma cell line, encoding the same
protein (Kudoh unpublished, accession number AF175409). In situ hybridisation
studies done in our group revealed the presence of shrew-1 cDNA in carcinomas of
kidney, breast, lung, liver and pancreas (Klemmt, unpublished). However, the
presence of shrew-1 was also detected in normal tissues as well, such as in kidney,
pancreas, spleen. This led to the idea that shrew-1 is a molecule that plays a role
both in normal and invasion associated processes in higher vertebrates, since its
orthologs were identified only in mouse and zebra fish.
The shrew-1 protein was predicted by computational analysis to consist of an
unusually long signal peptide of 43 amino acids, an ectodomain, a transmembrane
domain, and a cytoplasmic domain, which are all attributes of a transmembrane
protein. Further experiments were done in the direction to prove the functional
integrity of these domains. It could be shown by immunofluorescence and by
biotinylation experiments that shrew-1 is indeed an integral membrane protein and a
part of it is outside the cell. The orientation of at least the carboxyl terminal domain
could be shown to be cytoplasmic by permeabilization studies using shrew-1-GFP
tagged at the C-terminus. However, the amino-terminus could not be well-73
characterised due to inability to express the protein with an N-terminal tag.
Furthermore, the putative signal peptide of shrew-1 did not seem to be important for
the targeting of the protein to the plasma membrane. Shrew-1 was cloned without
the putative signal peptide with a C-terminus GFP tag (∆1-43)and the cellular
localization was studied (Jakob, unpublished). ∆1-43 targeted to the membrane and
showed similar biotinylation pattern as full length shrew-1. Obviously the membrane
targeted signal is present elsewhere, most probably in the transmembrane domain
which is highly hydrophobic in nature. Taken together, it could be said that shrew-1
is an integral membrane protein with a cytoplasmic C-terminus.
Figure 27. Specific expression of endogenous shrew-1 (green) in proliferating human keratinocytes
as detected by the monoclonal antibody raised against the putative ectodomain of shrew-1 (Catherin
Niemann, unpublished). Cornifin is taken as a marker for the keratinocytes and is seen as red,
whereas To-Pro3, a marker for the nucleus, is seen in blue.
The endogenous expression of shrew-1 was detected by generating two different
types of antibodies, raised against different shrew-1 peptides. A monoclonal
antibody was raised against a peptide present in the putative ectodomain of
shrew-1, the part containing the low complexity region and the polyclonal antibody
was generated against carboxyl terminus peptides. Both the antibodies in an
immunoblot detected a protein of about 45 kDa, the expected size of shrew-1. The
authenticity of the detected shrew-1 band was confirmed by immunoprecipitating
shrew-1 cornifin To-Pro3 shrew-1 cornifin To-Pro374
shrew-1 with the monoclonal antibody and immunoblotting with the polyclonal
antibody and vice versa, since it is extremely unlikely that both peptide sequences
used as immunogen would be present in a protein unrelated to shrew-1 (Bharti et
al., in press).
The presence of shrew-1 protein in carcinomas tested positive for shrew-1 mRNA
was confirmed using these antibodies (preliminary data). Carcinomas of pancreas,
liver, lung, kidney and endometrium tested positive for shrew-1. Interestingly, shrew-
1 was found to be specifically expressed in proliferating keratinocytes in sections
from skin tissue (Fig. 27) (Cathrin Niemann, Cancer research laboratories, UK).
4.2.     Specific targeting of shrew-1 to the basolateral membrane
The next question that arose after observing the targeting of shrew-1 to the
membrane was whether it targets specifically to any particular domain, i.e. apical or
basolateral in polarised cells. It is well known that epithelial cells sort plasma
membrane proteins into polarized apical and basolateral domains to perform
vectorial secretory and transport functions that are critical for cellular, tissue and
organism homeostasis. Shrew-1 was found to target specifically to the basolateral
part of the membrane in polarised MDCK cells, as shown by confocal microscopy
(Fig. 15). The basolateral targeting of shrew-1 might have important consequences
for the maintenance of adherens junctions, as is known for several other basolateral
targeting proteins. One example is LET-413 (similar to human ERBIN), a C.elegans
protein that is basolaterally localised and is shown to be essential for the assembly
of adherens junctions (Legouis et al., 2000). LET-413 supposedly forms a scaffold
with proteins containing PDZ domains, within the basolateral domain to assemble
adherens junctions.
The mutants of LET-413 are known to show defects in epithelial integrity that leads
to an abnormal morphogenesis of the pharynx, intestine and pharynx-epithelia
derived structures (Legouis et al., 2000). Another well-known example is E-
cadherin, one of the proto-typical polarized membrane proteins in epithelia. It is
delivered to the basolateral membrane
 and is concentrated in adherens junctions
where it participates
 in cell-cell adhesion (Le Bivic et al., 1990., Shore and Nelson,
1991). It is indispensable for the structural and functional integrity of the adherens75
junctions where it complexes with other cytoplasmic proteins and associates with
the cytoskeleton, further stabilising the intercellular contacts (Gumbiner, 1996;
Takeichi, 1995).
Along these lines, it would be reasonable to assume that the localisation and
concentration of shrew-1 at the basolateral part of the plasma membrane might play
a role in the process of cell-cell adhesion. This assumption is based on the initial
line of evidence about association of shrew-1 with invasiveness. Mistargeting of
shrew-1 by mutations or its deregulation could direct the cell to an invasive or
abnormal phenotype.
To understand the role of shrew-1 at the basolateral part of the membrane, it would
be first important to unravel the mechanism of its sorting to the basolateral
membrane. The mechanisms for sorting and targeting proteins to the apical and
basolateral surfaces are still only partially understood. Sorting of basolateral
proteins has been shown to depend on short amino acid sequences located in the
cytoplasmic tail that interact with specific adaptor proteins (Aroeti
 et al., 1998). This
suggests that basolateral targeting is mediated by direct interaction with vesicle coat
components (Puthenveedu et al., 2003).
Different classes of signals have been identified for this targeting.
 The most frequent
and best-characterized sequences depend on a
  critical tyrosine residue within a
consensus sequence Tyr-X-X-Ф,
 where Ф is a bulky hydrophobic residue (Matter et
al., 1992). Most of these tyrosine
 based-signals may also function as signals for
rapid endocytosis.
 Less common signals include Leu-Leu and di-hydrophobic motifs
(Hunziker and Fumey, 1994) or short sequences with no apparent
  consensus
(Hobert et al., 1997). It is quite possible that shrew-1 targets to the basolateral
domain with the less common or relatively unknown signals since a scan of the
shrew-1 amino acid sequence did not reveal any of the above mentioned motifs. It is
not such a unique case since the basolateral targeting of neural cell adhesion
molecule
 (N-CAM) also has been attributed to a cytoplasmic tail sequence without
classic motif homology (Le Gall et al., 1997).
The approach used by Miranda et al (2001) for identification of basolateral targeting
signals of E-cadherin, could also be applied to identify the basolateral targeting76
signal of shrew-1. They created chimaeras of Tac (the α subunit of the IL-2
receptor) and E-cadherin containing the cytoplasmic tail of E-cadherin and
alternatively some sequences from the cytoplasmic domain. Tac is a 273-amino
acid protein that has been used as a reporter protein for trafficking studies
(Rajasekaran et al., 1994; Mallet and Maxfield 1999). These chimaeras were
efficiently targeted
 and trafficked to the basolateral domain of MDCK and LLC-PK1
cells
 in a similar manner to that of endogenous E-cadherin or GFP-E-cadherin
 in
either cell line. Using this model system a positive
 targeting signal in E-cadherin was
identified that is responsible for its basolateral
 delivery.
4.3.     Shrew-1 as an integral component of adherens junctions (AJs)
4.3.1.     Shrew-1 complexes specifically with E-cadherin-β-catenin complexes
The identification of shrew-1 as an integral membrane protein targeted basolaterally
raised the important question about its importance as a junctional component. Since
the basolateral part is rich in junctions, attention was mainly focussed on adherens
junctions (AJs) that are the most well-characterised intercellular junctions.
E-cadherin, a well-studied prototype member of AJS (see Introduction) was taken
as a marker protein, especially for the reason that shrew-1 is also targeted
basolaterally. Colocalisation studies done with confocal microscopy showed that
both of these proteins colocalise, especially in epithelial polarised cells.
Interestingly, the disruption of the junctions by a physiological stimulus, scatter
factor/hepatocyte growth factor (SF/HGF) elicited a similar response by shrew-1 and
E-cadherin, both of them translocated intracellularly, most probably in the same
structures. The removal of the stimulus led to the redistribution of these proteins on
the membrane at the same time points (Fig. 19). Following these interesting
observations, interaction assays were performed with shrew-1 and E-cadherin
which showed, not so surprisingly though, a complexing between these two
proteins. This complexing was quite specific and was limited to polarised epithelial
cells since shrew-1 did not show any complexing with N-cadherin from invasive,
non-polarised epithelial cells. It was established by this data that shrew-1 is a novel
protein of the epithelial AJs that complexes specifically with E-cadherin.77
The targeting of shrew-1 to the AJs could be mediated by a plethora of proteins, β-
catenin being a potential candidate. It could indeed be shown by interaction studies
that shrew-1 interacts directly with β-catenin via its cytoplasmic domain. Direct
interaction between β-catenin and shrew-1 in an in vitro pull-down assay suggested
that shrew-1 might be linked to the E-cadherin-mediated junctional complex via β-
catenin. This interpretation also raises the possibility that shrew-1 is in fact targeted
to specific cell contact sites, e.g. adherens junctions, rather than merely binding to
E-cadherin  per se. In line with such an idea is the observation that
coimmunoprecipitation of shrew-1 with the E-cadherin-catenin complex was
dependent on the formation of junctions and, in spite of colocalisation in
immunofluorescence between shrew-1-GFP and endogenous E-cadherin,
complexing could not be observed in subconfluent cells. An explanation for lack of
complexing observed in subconfluent cells could be that the interaction is rather
weak at this stage of cell growth and only stabilises when cellular junctions mature
in confluent cells. The second explanation could be that initially E-cadherin and
shrew-1 are in two independent complexes which only interact in rather mature
junctions. This might be a sort of anchoring requiring additional bridging protein(s),
one interesting candidate being caveolin-1, since it is now known that basolateral
targeting of membrane proteins is mediated exclusively by direct interaction with
vesicle coat components (Puthenveedu et al., 2003) and caveolin-1 is one of them
(described later in detail).
The fact that no interaction could be found between shrew-1 and N-cadherin-β-
catenin complex in non-polarised cells however favours the idea that β-catenin
alone is not sufficient to target shrew-1 into adherens junctions, but other, as yet
unidentified components might also be necessary. One component could be
E-cadherin itself, although it was not possible to identify a direct interaction between
full-length E-cadherin and the cytoplasmic domain of shrew-1 in vitro with the used
assay conditions. The possibility that an interaction between E-cadherin and shrew-
1 might be mediated via the transmembrane and/or the extracellular domains of
shrew-was explored by performing in vivo interaction assays between E-cadherin
and the deletion mutants of shrew-1 (Fig. 26). Both the ectodomain and the
cytoplasmic domain fused to the transmembrane domain showed a complexing with
E-cadherin, suggesting that the transmembrane domain is quite important for this78
interaction. However, a stronger complexing was obtained with the cytoplasmic
domain fused to the transmembrane domain, suggesting the presence of
basolateral targeting signals in the cytoplasmic domain that target shrew-1 to the
basolateral part of the membrane where shrew-1 and E-cadherin interact.
4.3.2.     Probable role of shrew-1 in the regulation of Adherens Junctions
From the observations made till now, one could hypothesise that shrew-1 as an
integral component of cadherin-catenin complexes at the AJs might play a role in
the regulation of these junctions. Since an important aspect of junctional regulation
is the balance of the components of the junctions, it seems that a disturbed shrew-1
expression or overexpression leads to junctional disruption and invasiveness in
general. This is in agreement with the fact that shrew-1 was isolated from an
epithelial endometriotic cell line, EEC145T that does not contain any E-cadherin
based adherens junctions. The cells turn non-invasive and lose shrew-1 at the same
time, hence supporting the hypothesis that shrew-1 plays some role in the
regulation of molecules associated with invasion.
On the other hand, it was also seen that shrew-1 is present in some normal
epithelial tissues such as kidney, suggesting its positive role in mediating cell-cell
adhesion by interaction with E-cadherin-catenin complexes.
Taken together, this suggests that the positive regulation of shrew-1 is associated
with its association with E-cadherin-catenin complexes and its negative regulation,
which occurs in E-cadherin negative cells, as seen with EEC145T which is
N-cadherin positive, leads to invasion. This is supported by the result that shrew-1
complexes specifically with E-cadherin-catenin complexes but not with N-cadherin-
catenin complexes, hence strengthening the hypothesis that it strictly needs to
associate with E-cadherin to function as a positive regulator of cell adhesion.
4.4.     shrew-1 stable cell line
A direct evidence supporting the above mentioned hypothesis came from
observation that a wild type MDCK cell line turned invasive when transfected stably
with shrew-1. The normal honey-combed morphology that is typical of MDCK cells
was lost and instead the cells had a transformed phenotype. The E-cadherin and β-
catenin staining was no more regular, albeit was quite fuzzy and at times a partially79
cytoplasmic staining was also seen especially for β-catenin. The cells apparently
could not tolerate such high amounts of shrew-1 since they lost its expression after
4-5 passages, obviously implying that shrew-1 is toxic for the cells. Apart from the
unusual E-cadherin staining that exhibited the loss of strong intercellular contacts,
the cytoplasmic β-catenin staining was quite perplexing. This kind of staining is
observed only when the cytoplasmic pool of β-catenin does not undergo
degradation because of phosphorylation at its serine/threonine residues by GSK-3 β
as a result of which it is activated and translocates to the nucleus inducing the
transcription of certain oncogenes (Behrens et al., 1998; Hart et al., 1998; Ikeda et
al., 1998). A detailed inspection into this observation was done and activation of β-
catenin was measured by TOP Flash assays. In accordance with the
immunofluorescence result, a high amount of activated β-catenin was measured in
shrew-1-GFP stable cell line as compared to the GFP alone or untransfected MDCK
cell line. Although on one hand this result provided further evidence to strengthen
the belief about the association of shrew-1 with invasiveness, there was an obvious
discrepancy in this result obtained between shrew-1 cell lines transfected transiently
and stably. The explanation for this discrepancy would be that the large amounts of
shrew-1 present in all cells instead of a small number of cells (when transfected
transiently) transmits signals to the neighbouring cells for junction disruption. It is
most likely that a small number of cells overcome this effect of shrew-1
overexpression since all the cells in the neighbourhood have normal junctions and
cell-cell adhesion is a process involving adjacent cells. Nevertheless, this cell line
could provide a useful tool to gather more information about the mechanism behind
the association of shrew-1 in invasive processes.80
4.4.1.   Study of β-catenin and the mechanism behind its activation in the
shrew-1 stable cell line
The dissociation of catenins from cadherins in response to different stimuli is a well
known phenomenon (Kinch et al., 1995). Normally the β-catenin released from E-
cadherin complex is targeted for degradation by forming a complex with APC which
then triggers the ubiquitin-mediated β-catenin degradation (Bienz, 1999). The β-
catenin molecules that escape this degradation are targeted to nucleus where they
heterodimerise with TCF/Lef transcription factor and initiate the expression of
several oncogenes. In the case of shrew-1 stables, one could postulate that there is
excess of β-catenin that is dissociated most probably as an after effect of disruption
of cadherin-catenin complexes at the AJs or by competitive binding of excess
shrew-1 to β-catenin hence decreasing the amount of β-catenin available to E-
cadherin to form strong adhesion complexes at the junctions. This excess β-catenin
does not form complexes with APC and GSK-3β.
To further understand this phenomenon induced by shrew-1, it would be worthwhile
to test whether shrew-1 still complexes with E-cadherin and whether the interaction
between E-cadherin and β-catenin still persists in this stable cell line. Lack of
interaction would support the hypothesis that shrew-1 plays an important role in the
maintenance of junctions via its complexing with E-cadherin.
Another level of regulation of adherens junctions is mediated by Rac1 which
participates in clathrin independent endocytosis of E-cadherin in an actin-dependent
manner (Akhtar and Hotchin, 2001). This group showed the involvement of Rac1 in
disrupting the junctions by a physiological stimulus and observed that E-cadherin is
endocytosed into intracellular vesicles that are coated with Rac1 and caveolin-1.
This endocytosis was found to be clathrin-independent. The endocytosed E-
cadherin is not targeted for degradation albeit for recycling which has important
implications for tissue remodelling events, such as wound healing, where dynamic
regulation of E-cadherin is required for the continual disruption and formation of cell-
cell contacts.81
Keeping in mind the observation that shrew-1 colocalises with E-cadherin in
intracellular compartments on disruption of junctions by a physiological stimulus,
SF/HGF, it would be quite interesting to know whether Rac1 is also involved in the
endocytosis of shrew-1 and whether shrew-1 also colocalises with caveolin-1,
similar to E-cadherin. Caveolin-1 is known to form complexes with E-cadherin-β-
catenin complex by direct interaction with β-catenin by which it recruits β-catenin to
the caveolae and inhibits Wnt signaling (Galbiati et al., 2000) .
4.5.     Shrew-1 and Caveolin-1
Interestingly, it could be shown that endogenous caveolin-1 not only localises with
shrew-1 but also interacts with it both in in vivo and in vitro assays. It is known from
the literature and the previous findings that caveolin-1 interacts directly with β-
catenin and forms a complex with E-cadherin-β-catenin complex (Galbiati et al.,
2000). In additions it has been demonstrated in this study that shrew-1 also
associates with the cadherin-catenin complex (Bharti et al., in press). Taken
together, this data shows very clearly that shrew-1 is present in the same complex
with E-cadherin-β-catenin and with caveolin-1, both being key players in the process
of invasion by acting as tumor processors (see Introduction).
It can also be assumed that shrew-1 might target basolaterally via its association
with caveolin-1, since it is known that basolateral targeting is mediated by
interaction with adaptor proteins/vesicle coat components (Puthenveedu et al.,
2003), caveolin-1 being one.
Although the functional relevance of this complexing is not known, one could
hypothesise that shrew-1 itself is a coat component of the vesicles involved in the
recycling of basolaterally targeted proteins during endocytosis and leads to the
proper targeting of E-cadherin to the basolateral part of the membrane.
The polarized targeting of E-cadherin is of seminal importance to the maintenance
of epithelial polarity and function. The accurate basolateral delivery
  of newly
synthesized E-cadherin and of internalized and recycled
  E-cadherin is quite
important for its incorporation into adherens junctions. In the absence or82
deregulation of this mechanism, no cell-cell adhesion is possible driving the cell
towards invasiveness. In the context of shrew-1 invasive cell line, it could be
assumed that the deregulation of shrew-1 does not ensure the proper targeting of E-
cadherin to the junctions, hence the cell turns invasive. However, this is just an
assumption which requires further experimental evidence. To prove this concept, it
would be important to perform electron microscopical analysis of shrew-1
localisation, whether it is present in the same endocytotic vesicles with caveolin-1
before and after disruption of the membrane via SF/HGF.
The presence of low complexity regions in shrew-1 (Peer Bork and Gisbert
Schneider, personal communications) for which no structure can be predicted with
the algorithms available might be significant here (Shultz et al., 1998). One general
idea about the functional relevance of these low complexity regions is that they only
acquire a rigid structure (e.g. an α-helix) upon interaction with another protein
partner or oligomerization into a protein complex (Wright and Dyson, 1999). This
feature of shrew-1 is quite reminiscent of SNAREs. SNAREs are known to be key
players of vesicle docking and fusion, and only form an α-helix when they bind to
their interaction partner (Fasshauer et al., 1997; Jahn and Sudhof, 1999). This
similarity increases the possibility of association of shrew-1 with endocytosis.
Interestingly, similar lack of structure to shrew-1 has also been seen in clathrin
accessory factors such as epsin, which perform regulatory or catalytic functions at
specific stages in endocytosis (Hurley and Wendland, 2002).
4.6.     Future characterisation of shrew-1
In this work, shrew-1 has been identified as an integral component of the AJs that
complexes on the one hand with E-cadherin and on the other hand with caveolin-1.
Its association with polarisation has been shown with it specific complexing with
cadherin-catenin complexes of epithelial polarised cells but not with the cadherin-
catenin complexes in non-polarised, invasive cells (Bharti et al., in press).
To decipher its precise biological function in junction regulation and/or endocytosis,
some further steps have to be taken and some other biological models have to be
utilised. One of them would be the Identification of some yet unknown interaction
partners at the membrane decipher its biological role, since shrew-1 is an integral83
component of the plasma membrane. Some of the methods that can be used to
identify its interaction partners at the membrane are described below:
• Yeast spilt ubiquitin interaction analysis:  The yeast two-hybrid system is a
powerful method for the in vivo analysis of protein-protein interactions and is also
used for identifying unknown interaction partners (Bartel and Fields, 1995).
However, it is not applicable for shrew-1 since it is limited to the analysis of soluble
proteins or soluble domains of membrane proteins, i.e. interactions between integral
membrane proteins cannot be studied. The split ubiquitin system has emerged as a
valuable system to study the interactions between membrane proteins at their sites
of interaction (Johnsson and Varshavsky, 1994). As a result the complete integral
membrane protein can be used for interaction studies. This system basically
involves one of the interaction partners to be fused to the C-terminus of ubiquitin
which is tagged to a reporter protein and the other partner to the N-terminus of
ubiquitin. In case of an interaction, the native ubiquitin is reconstituted and is
cleaved by ubiquitin-specific proteases. This cleavage is visualised by the reporter
protein attached to the C-terminus of ubiquitin. Considering the fact that shrew-1 is
a mammalian membrane protein with no orthologs in yeast (Bharti et al., in press),
its insertion into the yeast membrane may be different from its insertion into
mammalian cells. Taking this situation into account, the split ubiquitin system is
being established for use in mammalian cells (Schreiner, unpublished).
• Bimolecular fluorescence complementation (BiFC) assay: BiFC assay is an
improvised version of fluorescence resonance energy transfer (FRET) to determine
the localisation of protein interactions in living cells (Hu et al., 2002). The BiFC
approach is based on complementation between two nonfluorescent fragments of
the yellow fluorescent protein (YFP), when they are brought together by interactions
between proteins fused to each fragment. The BiFC analysis was done to study
interactions among bZIP and Rel family proteins (Hu et al., 2002) and has several
advantages over other methods for the investigation of protein interactions in cells.
1.  Direct visualisation of protein interactions in their normal cells.
2.  The sensitivity of this method is enough to enable analysis of interactions
between proteins expressed at levels comparable to many endogenous proteins.84
This is essential to ensure that complex formation occurs under conditions similar to
those experienced by the native proteins.
3.  This system allows detection of weak and transient interactions as well,
which is not possible with most other systems. Moreover, the subcellular sites of
protein interactions can be determined.
This system can be exploited to determine the direct interaction between shrew-1
and E-cadherin since it was never possible to visualise this with an in vitro pull down
assay due to the inability to express either of the two transmembrane proteins in
bacteria. An identification of a direct interaction would provide an answer to the
question whether shrew-1 is targeted to the AJs via E-cadherin or whether it is
targeted per se.
4.7.     Genetic models of shrew-1
No counterparts of shrew-1 were identified in Drosophila, yeast or C.elegans albeit
in zebrafish and mouse, thus implying that shrew-1 is conserved only in vertebrates
and might have a role to play in higher order tissue organisation. The shrew-1
zebrafish sequence was found to have sequence similarity with shrew-1 human
sequence within the transmembrane and the cytoplasmic domain (Fig. 28). This is
actually quite interesting since these domains of shrew-1 have been characterised
(see Results section) for their membrane targeting and for their complexing with E-
cadherin. The study of shrew-1 in zebra fish might yield some results leading to
understanding of its biological role. The zebrafish Danio rerio is an emerging model
organism for understanding vertebrate development and genetics. The similarity
between humans
  and zebrafish, in terms of disease, extends beyond gene
homology
 to actual similarities in the proteins involved in pathogenesis (Postlethwait
et al., 2000).85
human                     1     MWIQQLLG LSSMSIRW-PGRpLGSHAWI LIAMFQLAVD LPACEALGPG
mouse                     1     MWIQQLLG LSSMSIRW-PGRSLGSHAWI LIAMLQLAVD FPSCDSLGPG
zebrafish                 1                 SLVAWrPGGILGCRMWI LFILVHLTMD LSLCAPPGQG
human                    48   PEFWLLPRSP PRPPRLW-SFRSGQPARVPA PVWSPRPPRV ERIHG--QMQ
mouse                    48   PEFRLLSR-P QRPQRLW-SLRSGPPTRLPT PAWSPRAARA ERAHGpiQMQ
zebrafish                51   LTLKLLPRSV PRqqlhplSTLTGQHLRTLG VLHRVLPPPL PSVGN--HGE
human                    95   MPRARRAHRP RDQAAALVPKAGLAKPPAAA KSSPSLASSS SSSSSAVAGG
mouse                    96   TPRARRAHRP RDQVATLGPKGGLTKPPAAT RSSPSLA-SA TASSSIVTAG
zebrafish                99   QGGTKLLGRk srrsiqkrql ctkceltp-- -------SDK GKSVTLAEGS
human                   145   APEQQALLRR GKRHLQG---DglsSFDSRG SRPTTETEFI AWGPTGDEEA
mouse                   145   AAEHQGLLRR GRRHthdtef N--DFDFRG GRPTTETEFI AWGPTGDEDA
zebrafish               140   KSDVNQHLSR SRRQLKG--- D---YDSLE GRTTTVAGFI DWGPTGADEG
human                   192   LESNTFPGvY GPTTVSILQT KTTVAATTT TT--TTATPM TLQTKGFTES
mouse                   192   LESNTFPGgF GPTTVSILQT KTTVATTTT TTAGSTATAM TLQTKGVTES
zebrafish               184   IEeeakvtpn a--TVTSLAP TTTVTITST TTRSPQRTYA VITTahpkrh
human                   240   LDPRRRIPGG VSTTEPSTSP NNGEVTQPP RILGEASGLA VHQIITITVS
mouse                   242   LDPWKRTPVG VSTTEPSTSP SNGkdiQPP RILGETSGLA VHQIITITVS
zebrafish               232   s--------- ------TTQP NSRVTAKPP KPFGDTPGLA VHQIITITVS
human                   290   LIMVIAALIT TLVLKNCCAQ GNTRRNSHQ RKTNQQEESC QNLTDFpsAR
mouse                   292   LIMVIAALIT TLVLKNCCAP GHTRRNSHQ RKMNQQEESC QNLTDFTPAR
zebrafish               267   LIMIVAALIT TLVLKNCCAQ GNGRHSSHQ RKINQQEESC QNLTDFTPAR
human                   340   VPSSLDIFTA YNETLQCSHE VRASVPVYT DETLHSTtGE YKSTFNGNR-
mouse                   342   VPSSVDIFTA YNETLQCSHE VRASVPVYA DETLHST-GE YKSTFNGNR-
zebrafish               317   VSSKVDIFTA YNDSLQCSHECVRAGIPVYT DEMIQHT-PI YKTSYNGNRq
human                   389   -PSSSDRHLI PVAFVSEKWF EISC
mouse                   390   -TSSADRHLI PVAFVSEKWF EISC
zebrafish               366   ePSPTERQLI PVAFVSEKWF EISC
Figure 28. Comparison of shrew-1 protein sequences from human, mouse and zebrafish.
It is possible to design morpholinos, which are basically a stretch of nucleotides
complementary to the mRNA sequence and when injected into the organism, forms
a double stranded RNA as a consequence of which the whole RNA is degraded.
This method is known to work most elegantly in zebra fish where the effect can be
seen within 48h. By using caged morpholinos which can be activated when desired,
role of shrew-1 during different stages of embryonic development can be
deciphered.
More than 90% homology has been found between protein sequences of shrew-1
from mouse and human. The mouse shrew-1 protein was also found to be localised
at the same position as its human counterpart because of this strong homology
(Franke, unpublished). Apparently the regulation of shrew-1 is important for its role
as an invasion associated protein of the adherens junctions. To study the spatio-
temporal regulation of shrew-1, it would be important to study its tissue specific as86
well as development stage specific regulation. For these studies, the mouse system
is a beneficial tool.
Tissue specific knock outs of shrew-1 using Cre-lox system (Lakso et al., 1992) can
be easily created in mouse whereby the specific regulation of shrew-1 in different
tissues can be identified. Additionally, the regulation pattern of shrew-1 during
different stages of development can also be studied.87
5.     Summary
In an attempt to search for potential candidate molecules involved in the
pathogenesis of endometriosis, a novel 2910 bp cDNA encoding a putative 411
amino acid protein, shrew-1 was discovered. By computational analysis it was
predicted to be an integral membrane protein with an outside-in transmembrane
domain but no homology with any known protein or domain could be identified.
Antibodies raised against the putative open-reading frame peptide of shrew-1
labelled a protein of ca. 48 kDa in extracts of shrew-1 mRNA positive tissues and
also detected ectopically expressed shrew-1. In the course of my PhD work, I
confirmed the prediction that shrew-1 is indeed a transmembrane protein, by
expressing epitope-tagged shrew-1 in epithelial cells and analysing the transfected
cells by surface biotinylation and immunoblots. Additionally, I could show that
shrew-1 is able to target to E-cadherin-mediated adherens junctions and interacts
with the E-cadherin-catenin complex in polarised MCF7 and MDCK cells, but not
with the N-cadherin-catenin complex in non-polarised epithelial cells. A direct
interaction of shrew-1 with β-catenin could be shown in an in vitro pull-down assay.
From this data, it could be assumed that shrew-1 might play a role in the function
and/or regulation of the dynamics of E-cadherin-mediated junctional complexes.
In the next part of my thesis, I showed that stable overexpression of shrew-1 in
normal MDCK cells. causes changes in morphology of the cells and turns them
invasive. Furthermore, transcription by β-catenin was activated in these MDCK cells
stably overexpressing shrew-1. It was probably the imbalance of shrew-1 protein at
the adherens junctions that led to the misregulation of adherens junctions associated
proteins, i.e. E-cadherin and β-catenin.
Caveolin-1 is another integral membrane protein that forms complexes with E-
cadherin-β-catenin complexes and also plays a role in the endocytosis of E-cadherin
during junctional disruption. By immunofluorescence and biochemical studies,
caveolin-1 was identified as another interacting partner of shrew-1. However, the
functional relevance of this interaction is still not clear.88
In conclusion, it can be said that shrew-1 interacts with the key players of invasion
and metastasis, E-cadherin and caveolin-1, suggesting its possible role in these
processes and making it an interesting candidate to unravel other unknown
mechanisms involved in the complex process of invasion.89
6.     Zusammenfassung
Auf der Suche nach Molekülen, die potentiell zur Pathogenese der Endometriose
betragen könnten, wurde eine 2910 bp große cDNA identifiziert, die für ein bisher
unbekanntes, hypothetisches Protein von 411 Aminosäuren codiert, das wurde
shrew-1 genannt wurde. Eine Computeranalyse der Proteinsequenz ergab, dass es
sich bei dem Protein um ein integrales Membranprotein handelt. Jedoch konnten
keinerlei Homologien mit bekannten Proteinen oder Proteindomänen festgestellt
werden.
Antikörper gegen zwei verschiedene Peptidsequenzen aus potentiellen offenen
shrew-1-Leserahmen markierten in Extrakten von shrew-1 positivem Gewebe ein
Protein von etwa 48 KDa. Ausserdem kann mit diesen Antikörpern ektopisch
exprimiertes shrew-1 nachgewiesen werden.
Im weiteren Verlauf der Doktorarbeit konnte durch die Expression epitop-„getaggten“
shrew-1 in Epithelzellen und der Untersuchung dieser tranfizierten Zellen mittels
Oberflächenbiotinylierung und Immunoblots sowie Immunfluoreszenzanalysen die
Computeranalyse bestätigt werden. Es zeigte sich, dass es sich bei shrew-1
tatsächlich um ein Transmembranprotein mit einem cytoplasmatisch lokalisierten
C-Terminus handelt.
Desweiteren wurde gefunden, dass shrew-1 an Adhäsionsverbindungen
transportiert wird, die durch E-Cadherin vermittelt werden. Shrew-1 interagiert mit
dem E-Cadherin-Catenin-Komplex polarisierter Epithelzellen (MCF7- oder MDCK-
Zellen). Im Gegensatz dazu kann in nicht-polarisierten Epithelzellen (EJ28-Zellen),
welche einen N-Cadherin-Catenin-Komplex enthalten, keine Interaktion
nachgewiesen werden. Eine direkte Interaktion von Shrew-1 mit β-Catenin in einem
in vitro „Pull-down-assay“ lässt vermuten, dass die Einbindung von shrew-1 in den
E-Cadherin-Catenin Komplex zumindest teilweise über β-Catenin erfolgen kann.
Die physiologische Auflösung der E-Cadherin-vermittelten Adhäsionskomplexe
durch die Aktivierung der Rezeptortyrosinkinase c-met führt, zusammen mit90
E-Cadherin, zu einer Internaliserung von shrew-1 in Vesikeln, vermutlich den
caveolae, in denen E-Cadherin und shrew-1 zu kolokalisieren scheinen.
Zusammmengefasst könnten diese Daten könnten darauf hinweisen, dass shrew-1
eine Rolle in der Funktion und/oder Regulation dynamischer Prozesse in
E-Cadherin-vermittelten Adhäsionsverbindungen spielen könnte.
Eine stabile Überexpression von shrew-1 in MDCK-Zellen zeigte, dass shrew-1
Veränderungen in der Zellmorphologie und, damit verbunden, der Invasivität der
Zellen verursacht. Ausserdem konnte in den shrew-1 transfizierten MDCK-Zellen
β-Catenin vermittelte Transkriptionsaktivierung beobachtet werden. Dies ist ist
möglicherweise darauf zurück zu führen, dass ein Ungleichgewicht des transfizierten
shrew-1 im Adhäsionskomplex eine Deregulation der dort befindlichen Proteine, wie
z.B. E-Cadherin und β-Catenin ergibt.
Caveolin-1 ist ein weiteres integrales Membranprotein, das mit E-Cadherin-β-
Catenin-Komplexen direkt interagieren kann. Außerdem spielt es eine Rolle bei der
Endozytose von E-Cadherin während der Auflösung von Adhäsionskomplexen
zwischen zwei Zellen. Durch Immunfluoreszenz und biochemische Untersuchungen
konnte Caveolin-1 in dieser Arbeit als ein weiterer Interaktionspartner von shrew-1
identifiziert werden. Eine funktionelle Relevanz dieser Interaktion ist zur Zeit
allerdings noch unklar.
Zusammenfassend kann gesagt werden, dass shrew-1 mit „Key-playern“ von
Invasion und Metastasierung, nämlich E-Cadherin und Caveolin-1, interagiert. Dies
deutet auf eine wichtige Rolle von shrew-1 in diesen Prozessen hin und macht es zu
einem interessanten Kandidaten, an dem weitere Mechanismen im komplexen
Prozess der Invasivität von Zellen erforscht werden können.91
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